Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 831 articles:
HTML format



Single Articles


    January 2021
  1. MITCHELL G, Leonard L, Carter G, Santin O, et al
    Evaluation of a 'serious game' on nursing student knowledge and uptake of influenza vaccination.
    PLoS One. 2021;16:e0245389.
    PubMed     Abstract available


  2. SONGANE M, Grossmann V
    The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.
    PLoS One. 2021;16:e0244722.
    PubMed     Abstract available


  3. KAINGA HW, Ssendagire S, Ssanyu JN, Nabukeera S, et al
    Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    PLoS One. 2021;16:e0243137.
    PubMed     Abstract available


  4. BARAL R, Levin A, Odero C, Pecenka C, et al
    Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0244995.
    PubMed     Abstract available


  5. MPOFU R, Otwombe K, Mlisana K, Nchabeleng M, et al
    Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
    PLoS One. 2021;16:e0241708.
    PubMed     Abstract available


  6. ATTWELL K, Lake J, Sneddon J, Gerrans P, et al
    Converting the maybes: Crucial for a successful COVID-19 vaccination strategy.
    PLoS One. 2021;16:e0245907.
    PubMed     Abstract available


  7. RODGERS LR, Streeter AJ, Lin N, Hamilton W, et al
    Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.
    PLoS One. 2021;16:e0246156.
    PubMed     Abstract available


  8. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    PubMed     Abstract available


  9. PRAYITNO A, Supriyatno B, Munasir Z, Karuniawati A, et al
    Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study.
    PLoS One. 2021;16:e0245789.
    PubMed     Abstract available


  10. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras.
    PLoS One. 2021;16:e0246379.
    PubMed     Abstract available


  11. SIMWAKA J, Seheri M, Mulundu G, Kaonga P, et al
    Rotavirus breakthrough infections responsible for gastroenteritis in vaccinated infants who presented with acute diarrhoea at University Teaching Hospitals, Children's Hospital in 2016, in Lusaka Zambia.
    PLoS One. 2021;16:e0246025.
    PubMed     Abstract available


  12. ASHFAQ UA, Saleem S, Masoud MS, Ahmad M, et al
    Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach.
    PLoS One. 2021;16:e0245072.
    PubMed     Abstract available


  13. LOPEZ MORENO G, Nirmala J, Goodell C, Culhane M, et al
    Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions.
    PLoS One. 2021;16:e0246690.
    PubMed     Abstract available


  14. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.
    PLoS One. 2021;16:e0246385.
    PubMed     Abstract available


  15. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination among older adults in nursing homes and daycare centers, Honduras.
    PLoS One. 2021;16:e0246382.
    PubMed     Abstract available


  16. VANNI T, Thome BDC, Oliveira MMM, Gattas VL, et al
    Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.
    PLoS One. 2021;16:e0246540.
    PubMed     Abstract available


  17. GOUGLAS D, Marsh K
    Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis.
    PLoS One. 2021;16:e0246235.
    PubMed     Abstract available


  18. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
    PLoS One. 2021;16:e0245894.
    PubMed     Abstract available


  19. CHANIE MG, Ewunetie GE, Molla A, Muche A, et al
    Determinants of vaccination dropout among children 12-23 months age in north Gondar zone, northwest Ethiopia, 2019.
    PLoS One. 2021;16:e0246018.
    PubMed     Abstract available


  20. LATKIN CA, Dayton L, Yi G, Colon B, et al
    Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.
    PLoS One. 2021;16:e0246970.
    PubMed     Abstract available


  21. LEE J, Yoon Y, Kim EJ, Lee D, et al
    23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method.
    PLoS One. 2021;16:e0246699.
    PubMed     Abstract available


  22. KOZAKOVA J, Krizova P, Maly M
    Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    PLoS One. 2021;16:e0247862.
    PubMed     Abstract available


  23. WAGAI JN, Rhoda D, Prier M, Trimmer MK, et al
    Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0247415.
    PubMed     Abstract available


  24. MOHAMMED SA, Workneh BD, Kahissay MH
    Knowledge, attitude and practice of vaccinators and vaccine handlers on vaccine cold chain management in public health facilities, Ethiopia: Cross-sectional study.
    PLoS One. 2021;16:e0247459.
    PubMed     Abstract available


  25. FORGACS D, Abreu RB, Sautto GA, Kirchenbaum GA, et al
    Convergent antibody evolution and clonotype expansion following influenza virus vaccination.
    PLoS One. 2021;16:e0247253.
    PubMed     Abstract available


  26. MATTER D, Potgieter L
    Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    PLoS One. 2021;16:e0248053.
    PubMed     Abstract available


  27. XU Z, Wu B, Topcu U
    Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach.
    PLoS One. 2021;16:e0247660.
    PubMed     Abstract available


  28. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    PubMed     Abstract available


  29. BOKHARAIE VS
    A study on the effects of containment policies and vaccination on the spread of SARS-CoV-2.
    PLoS One. 2021;16:e0247439.
    PubMed     Abstract available


  30. GERMANI F, Biller-Andorno N
    The anti-vaccination infodemic on social media: A behavioral analysis.
    PLoS One. 2021;16:e0247642.
    PubMed     Abstract available


  31. KARDANI K, Bolhassani A
    Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    PLoS One. 2021;16:e0247396.
    PubMed     Abstract available


  32. DE LUSIGNAN S, Hoang U, Liyanage H, Tripathy M, et al
    Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network.
    PLoS One. 2021;16:e0248123.
    PubMed     Abstract available


  33. JANG H, Ross TM
    Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.
    PLoS One. 2021;16:e0246613.
    PubMed     Abstract available


  34. OTIANG E, Thumbi SM, Campbell ZA, Njagi LW, et al
    Impact of routine Newcastle disease vaccination on chicken flock size in smallholder farms in western Kenya.
    PLoS One. 2021;16:e0248596.
    PubMed     Abstract available


  35. CHUKWUDOZIE OS, Gray CM, Fagbayi TA, Chukwuanukwu RC, et al
    Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    PLoS One. 2021;16:e0248061.
    PubMed     Abstract available


  36. SHINJOH M, Sugaya N, Yamaguchi Y, Ookawara I, et al
    Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
    PLoS One. 2021;16:e0249005.
    PubMed     Abstract available


  37. KURU O, Stecula D, Lu H, Ophir Y, et al
    The effects of scientific messages and narratives about vaccination.
    PLoS One. 2021;16:e0248328.
    PubMed     Abstract available


  38. EDWARDS B, Biddle N, Gray M, Sollis K, et al
    COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    PLoS One. 2021;16:e0248892.
    PubMed     Abstract available


  39. PROMPETCHARA E, Ketloy C, Tharakhet K, Kaewpang P, et al
    DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
    PLoS One. 2021;16:e0248007.
    PubMed     Abstract available


  40. KONDO KUNIEDA M, Manzo ML, Shibanuma A, Jimba M, et al
    Rapidly modifiable factors associated with full vaccination status among children in Niamey, Niger: A cross-sectional, random cluster household survey.
    PLoS One. 2021;16:e0249026.
    PubMed     Abstract available


  41. ACACIO S, Nhampossa T, Quinto L, Vubil D, et al
    Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence.
    PLoS One. 2021;16:e0249714.
    PubMed     Abstract available


  42. EYTHORSSON E, Asgeirsdottir TL, Erlendsdottir H, Hrafnkelsson B, et al
    The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.
    PLoS One. 2021;16:e0249497.
    PubMed     Abstract available


  43. STUURMAN AL, Rizzo C, Haag M
    Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
    PLoS One. 2021;16:e0248943.
    PubMed     Abstract available


  44. ACEVEDO-VILLANUEVA K, Renu S, Gourapura R, Selvaraj R, et al
    Efficacy of a nanoparticle vaccine administered in-ovo against Salmonella in broilers.
    PLoS One. 2021;16:e0247938.
    PubMed     Abstract available


  45. RAZA MT, Mizan S, Yasmin F, Akash AS, et al
    Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
    PLoS One. 2021;16:e0248001.
    PubMed     Abstract available


  46. RIOS-BLANCAS MJ, Lamadrid-Figueroa H, Betancourt-Cravioto M, Lozano R, et al
    Vaccination coverage estimation in Mexico in children under five years old: Trends and associated factors.
    PLoS One. 2021;16:e0250172.
    PubMed     Abstract available


  47. FRIDMAN A, Gershon R, Gneezy A
    COVID-19 and vaccine hesitancy: A longitudinal study.
    PLoS One. 2021;16:e0250123.
    PubMed     Abstract available


  48. ASSEN AM, Walkden-Brown SW, Stillman M, Alfirevich S, et al
    Comparison of tracheal and choanal cleft swabs and poultry dust samples for detection of Newcastle disease virus and infectious bronchitis virus genome in vaccinated meat chicken flocks.
    PLoS One. 2021;16:e0247729.
    PubMed     Abstract available


  49. OYO-ITA A, Bosch-Capblanch X, Ross A, Oku A, et al
    Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    PLoS One. 2021;16:e0248236.
    PubMed     Abstract available



  50. Expression of Concern: Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones.
    PLoS One. 2021;16:e0250485.
    PubMed    


  51. GONCALVES P, Saez-Lopez E, Carneiro S, Simoes MJ, et al
    Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme.
    PLoS One. 2021;16:e0250103.
    PubMed     Abstract available


  52. NJUMA LIBWEA J, A Fletcher M, Koki Ndombo P, Boula A, et al
    Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0250010.
    PubMed     Abstract available


  53. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    PubMed     Abstract available


  54. EL-ELIMAT T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, et al
    Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan.
    PLoS One. 2021;16:e0250555.
    PubMed     Abstract available


  55. BARAL R, Levin A, Odero C, Pecenka C, et al
    Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0250863.
    PubMed     Abstract available


  56. ADIL MAHMOUD YOUSIF N, Tsoungui Obama HCJ, Ngucho Mbeutchou YJ, Kwamou Ngaha SF, et al
    The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    PLoS One. 2021;16:e0245417.
    PubMed     Abstract available


  57. COUDEVILLE L, Jollivet O, Mahe C, Chaves S, et al
    Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    PLoS One. 2021;16:e0250797.
    PubMed     Abstract available


  58. ABEDIN M, Islam MA, Rahman FN, Reza HM, et al
    Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.
    PLoS One. 2021;16:e0250495.
    PubMed     Abstract available


  59. QIN W, Wang E, Ni Z
    Chinese consumers' willingness to get a COVID-19 vaccine and willingness to pay for it.
    PLoS One. 2021;16:e0250112.
    PubMed     Abstract available


  60. KARUNARATNE ND, Newkirk RW, Ames NP, Van Kessel AG, et al
    Effects of exogenous beta-glucanase on ileal digesta soluble beta-glucan molecular weight, digestive tract characteristics, and performance of coccidiosis vaccinated broiler chickens fed hulless barley-based diets with and without medication.
    PLoS One. 2021;16:e0236231.
    PubMed     Abstract available


  61. BAUM U, Kulathinal S, Auranen K
    Exposure misclassification bias in the estimation of vaccine effectiveness.
    PLoS One. 2021;16:e0251622.
    PubMed     Abstract available


  62. WOLFF E, Widgren K, Scalia Tomba G, Roth A, et al
    Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    PLoS One. 2021;16:e0251644.
    PubMed     Abstract available


  63. YOUNG LS, Danial Z
    Three pre-vaccine responses to Covid-like epidemics.
    PLoS One. 2021;16:e0251349.
    PubMed     Abstract available


  64. ISLAM MS, Kamal AM, Kabir A, Southern DL, et al
    COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence.
    PLoS One. 2021;16:e0251605.
    PubMed     Abstract available


  65. PILTCH-LOEB R, Savoia E, Goldberg B, Hughes B, et al
    Examining the effect of information channel on COVID-19 vaccine acceptance.
    PLoS One. 2021;16:e0251095.
    PubMed     Abstract available


  66. GRAEBER D, Schmidt-Petri C, Schroder C
    Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany.
    PLoS One. 2021;16:e0248372.
    PubMed     Abstract available


  67. SANO K, Saito S, Suzuki T, Kotani O, et al
    An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
    PLoS One. 2021;16:e0245244.
    PubMed     Abstract available


  68. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    PubMed     Abstract available


  69. ELIZONDO-ALZOLA U, G Carrasco M, Pinos L, Picchio CA, et al
    Vaccine hesitancy among paediatric nurses: Prevalence and associated factors.
    PLoS One. 2021;16:e0251735.
    PubMed     Abstract available


  70. LEVINE G, Salifu A, Mohammed I, Fink G, et al
    Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana.
    PLoS One. 2021;16:e0247485.
    PubMed     Abstract available


  71. ATUHAIRE DK, Muleya W, Mbao V, Niyongabo J, et al
    Molecular characterization and population genetics of Theileria parva in Burundi's unvaccinated cattle: Towards the introduction of East Coast fever vaccine.
    PLoS One. 2021;16:e0251500.
    PubMed     Abstract available


  72. CAINI S, Paget J, Spreeuwenberg P, Korevaar JC, et al
    Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees.
    PLoS One. 2021;16:e0249883.
    PubMed     Abstract available


  73. EZAJ MMA, Haque MS, Syed SB, Khan MSA, et al
    Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.
    PLoS One. 2021;16:e0252295.
    PubMed     Abstract available


  74. ZEIGLER DF, Gage E, Clegg CH
    Epitope-targeting platform for broadly protective influenza vaccines.
    PLoS One. 2021;16:e0252170.
    PubMed     Abstract available


  75. KITONSA J, Kamacooko O, Bahemuka UM, Kibengo F, et al
    Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.
    PLoS One. 2021;16:e0251992.
    PubMed     Abstract available


  76. CHE X, Liu Y, Wang J, Xu Y, et al
    Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
    PLoS One. 2021;16:e0251567.
    PubMed     Abstract available


  77. NIKOLOVSKI J, Koldijk M, Weverling GJ, Spertus J, et al
    Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults.
    PLoS One. 2021;16:e0251963.
    PubMed     Abstract available


  78. NAKPHOOK S, Patumanond J, Shrestha M, Prasert K, et al
    Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    PLoS One. 2021;16:e0253028.
    PubMed     Abstract available


  79. KHOU C, Diaz-Salinas MA, da Costa A, Prehaud C, et al
    Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
    PLoS One. 2021;16:e0252595.
    PubMed     Abstract available


  80. KAHANA D, Yamin D
    Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
    PLoS One. 2021;16:e0252510.
    PubMed     Abstract available


  81. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0252332.
    PubMed     Abstract available


  82. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed     Abstract available


  83. STUURMAN AL, Ciampini S, Vannacci A, Bella A, et al
    Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
    PLoS One. 2021;16:e0252836.
    PubMed     Abstract available


  84. STRODEL R, Dayton L, Garrison-Desany HM, Eber G, et al
    COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
    PLoS One. 2021;16:e0253208.
    PubMed     Abstract available


  85. LINKS IJ, Denholm LJ, Evers M, Kingham LJ, et al
    Is vaccination a viable method to control Johne's disease caused by Mycobacterium avium subsp. paratuberculosis? Data from 12 million ovine vaccinations and 7.6 million carcass examinations in New South Wales, Australia from 1999-2009.
    PLoS One. 2021;16:e0246411.
    PubMed     Abstract available


  86. PALMER EA, Penagaricano F, Vedovatto M, Oliveira RA, et al
    Effects of maternal gestational diet, with or without methionine, on muscle transcriptome of Bos indicus-influenced beef calves following a vaccine-induced immunological challenge.
    PLoS One. 2021;16:e0253810.
    PubMed     Abstract available


  87. RIVIERE C, Bell T, Cadot Y, Perodin C, et al
    Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti.
    PLoS One. 2021;16:e0252310.
    PubMed     Abstract available


  88. HANDEBO S, Wolde M, Shitu K, Kassie A, et al
    Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.
    PLoS One. 2021;16:e0253499.
    PubMed     Abstract available


  89. WARIRI O, Okomo U, Kwarshak YK, Murray KA, et al
    Timeliness of routine childhood vaccination in low- and middle-income countries, 1978-2021: Protocol for a scoping review to map methodologic gaps and determinants.
    PLoS One. 2021;16:e0253423.
    PubMed     Abstract available


  90. WAGAI JN, Rhoda DA, Prier ML, Trimner MK, et al
    Correction: Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0253670.
    PubMed     Abstract available


  91. KHAN MT, Islam R, Jerin TJ, Mahmud A, et al
    Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.
    PLoS One. 2021;16:e0253393.
    PubMed     Abstract available


  92. TUNGGAL HC, Munson PV, O'Connor MA, Hajari N, et al
    Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
    PLoS One. 2021;16:e0253265.
    PubMed     Abstract available


  93. WISNEWSKI AV, Campillo Luna J, Redlich CA
    Human IgG and IgA responses to COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0249499.
    PubMed     Abstract available


  94. SPARGO RM, Coetzer A, Makuvadze FT, Chikerema SM, et al
    Knowledge, attitudes and practices towards rabies: A survey of the general population residing in the Harare Metropolitan Province of Zimbabwe.
    PLoS One. 2021;16:e0246103.
    PubMed     Abstract available


  95. MCKUNE S, Serra R, Toure A
    Gender and intersectional analysis of livestock vaccine value chains in Kaffrine, Senegal.
    PLoS One. 2021;16:e0252045.
    PubMed     Abstract available


  96. RUJUMBA J, Akugizibwe M, Basta NE, Banura C, et al
    Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.
    PLoS One. 2021;16:e0253735.
    PubMed     Abstract available


  97. THANEE C, Kittikraisak W, Sinthuwattanawibool C, Roekworachai K, et al
    Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study.
    PLoS One. 2021;16:e0253561.
    PubMed     Abstract available


  98. DUTTA T, Agley J, Meyerson BE, Barnes PA, et al
    Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis.
    PLoS One. 2021;16:e0253318.
    PubMed     Abstract available



  99. Correction: Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0254616.
    PubMed     Abstract available


  100. AJOVALASIT S, Dorgali VM, Mazza A, d'Onofrio A, et al
    Evidence of disorientation towards immunization on online social media after contrasting political communication on vaccines. Results from an analysis of Twitter data in Italy.
    PLoS One. 2021;16:e0253569.
    PubMed     Abstract available


  101. PAWASKAR M, Burgess C, Pillsbury M, Wisloff T, et al
    Clinical and economic impact of universal varicella vaccination in Norway: A modeling study.
    PLoS One. 2021;16:e0254080.
    PubMed     Abstract available


  102. DAVAHLI MR, Karwowski W, Fiok K
    Optimizing COVID-19 vaccine distribution across the United States using deterministic and stochastic recurrent neural networks.
    PLoS One. 2021;16:e0253925.
    PubMed     Abstract available


  103. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    PubMed     Abstract available


  104. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    PubMed     Abstract available


  105. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    PubMed     Abstract available


  106. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
    The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
    PLoS One. 2021;16:e0254456.
    PubMed     Abstract available


  107. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    PubMed     Abstract available


  108. KOLLI SK, Salman AM, Ramesar J, Chevalley-Maurel S, et al
    Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    PLoS One. 2021;16:e0254498.
    PubMed     Abstract available


  109. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed     Abstract available


  110. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Retraction: Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0255347.
    PubMed    


  111. DITOSTO JD, Weiss RE, Yee LM, Badreldin N, et al
    Association of Tdap vaccine guidelines with vaccine uptake during pregnancy.
    PLoS One. 2021;16:e0254863.
    PubMed     Abstract available


  112. ALVAREZ MM, Bravo-Gonzalez S, Trujillo-de Santiago G
    Modeling vaccination strategies in an Excel spreadsheet: Increasing the rate of vaccination is more effective than increasing the vaccination coverage for containing COVID-19.
    PLoS One. 2021;16:e0254430.
    PubMed     Abstract available


    January 2020
  113. VAN DER LINDEN M, Imohl M, Perniciaro S
    Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2020;15:e0228126.
    PubMed     Abstract available


  114. PATIC A, Strbac M, Petrovic V, Milosevic V, et al
    Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.
    PLoS One. 2020;15:e0227413.
    PubMed     Abstract available


  115. LU C, Song G, Beale K, Yan J, et al
    Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines.
    PLoS One. 2020;15:e0216260.
    PubMed     Abstract available


  116. MUPERE E, Babikako HM, Okaba-Kayom V, Mutyaba RB, et al
    Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.
    PLoS One. 2020;15:e0218239.
    PubMed     Abstract available


  117. TOBIN GJ, Tobin JK, Gaidamakova EK, Wiggins TJ, et al
    A novel gamma radiation-inactivated sabin-based polio vaccine.
    PLoS One. 2020;15:e0228006.
    PubMed     Abstract available


  118. ZHAO LP, Fiore-Gartland A, Carpp LN, Cohen KW, et al
    Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
    PLoS One. 2020;15:e0226803.
    PubMed     Abstract available


  119. FELDMAN C, Dlamini SK, Madhi SA, Meiring S, et al
    The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.
    PLoS One. 2020;15:e0227945.
    PubMed     Abstract available


  120. FRIEDRICH F, Valadao MC, Brum M, Comaru T, et al
    Impact of maternal dTpa vaccination on the incidence of pertussis in young infants.
    PLoS One. 2020;15:e0228022.
    PubMed     Abstract available


  121. DUFOUR C, Fournier V, Giovenazzo P
    The impact of lowbush blueberry (Vaccinium angustifolium Ait.) and cranberry (Vaccinium macrocarpon Ait.) pollination on honey bee (Apis mellifera L.) colony health status.
    PLoS One. 2020;15:e0227970.
    PubMed     Abstract available


  122. NAIDU SK, Nabi R, Cheemarla NR, Stanfield BA, et al
    Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.
    PLoS One. 2020;15:e0228252.
    PubMed     Abstract available


  123. DEBELLUT F, Jaber S, Bouzya Y, Sabbah J, et al
    Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    PLoS One. 2020;15:e0228506.
    PubMed     Abstract available


  124. NONGNUCH A, Ngampongpan W, Srichatrapimuk S, Wongsa A, et al
    Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
    PLoS One. 2020;15:e0227719.
    PubMed     Abstract available


  125. AI CE, Steele M, Lopman B
    Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    PLoS One. 2020;15:e0228942.
    PubMed     Abstract available


  126. BAQUI AH, McCollum ED, Mahmud A, Roy A, et al
    Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh.
    PLoS One. 2020;15:e0228799.
    PubMed     Abstract available


  127. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0229009.
    PubMed     Abstract available


  128. LIU X, Liang B, Liu X, Amaro-Carambot E, et al
    Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.
    PLoS One. 2020;15:e0228572.
    PubMed     Abstract available


  129. LI XH, Vance GM, Cartwright J, Cao JP, et al
    Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs.
    PLoS One. 2020;15:e0229542.
    PubMed     Abstract available


  130. HU W, He M, Li L
    HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
    PLoS One. 2020;15:e0229327.
    PubMed     Abstract available


  131. KLEIN NP, Fireman B, Goddard K, Zerbo O, et al
    Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    PLoS One. 2020;15:e0229279.
    PubMed     Abstract available


  132. MILHAU N, Almouazen E, Bouteille S, Hellel-Bourtal I, et al
    In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus.
    PLoS One. 2020;15:e0229121.
    PubMed     Abstract available


  133. MUNUSAMY PONNAN S, Hayes P, Fernandez N, Thiruvengadam K, et al
    Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.
    PLoS One. 2020;15:e0229461.
    PubMed     Abstract available


  134. SARLI M, Novoa MB, Mazzucco MN, Signorini ML, et al
    A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
    PLoS One. 2020;15:e0229301.
    PubMed     Abstract available


  135. VIRNIK K, Rosati M, Medvedev A, Scanlan A, et al
    Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
    PLoS One. 2020;15:e0228163.
    PubMed     Abstract available


  136. JIMENEZ AV, Mesoudi A, Tehrani JJ
    No evidence that omission and confirmation biases affect the perception and recall of vaccine-related information.
    PLoS One. 2020;15:e0228898.
    PubMed     Abstract available


  137. FAKHRI O, Devlin JM, Browning GF, Vaz PK, et al
    Genomic recombination between infectious laryngotracheitis vaccine strains occurs under a broad range of infection conditions in vitro and in ovo.
    PLoS One. 2020;15:e0229082.
    PubMed     Abstract available


  138. CHAPARRO RM, Rodriguez B, Maza Y, Moyano D, et al
    Factors associated with hindering the acceptance of HPV vaccination among caregivers - A cross-sectional study in Argentina.
    PLoS One. 2020;15:e0229793.
    PubMed     Abstract available


  139. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Correction: Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0230949.
    PubMed     Abstract available


  140. CHIRKOVA T, Ha B, Rimawi BH, Oomens AGP, et al
    In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    PLoS One. 2020;15:e0229660.
    PubMed     Abstract available


  141. COSTA AS, Gomes JM, Germani ACCG, da Silva MR, et al
    Knowledge gaps and acquisition about HPV and its vaccine among Brazilian medical students.
    PLoS One. 2020;15:e0230058.
    PubMed     Abstract available


  142. HJALMARSDOTTIR MA, Haraldsson G, Quirk SJ, Haraldsson A, et al
    Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.
    PLoS One. 2020;15:e0230332.
    PubMed     Abstract available


  143. ZHANG J, He J, Li J, Zhou Q, et al
    The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis.
    PLoS One. 2020;15:e0230381.
    PubMed     Abstract available


  144. HAO S, Wang C, Liu S, He J, et al
    HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
    PLoS One. 2020;15:e0230640.
    PubMed     Abstract available


  145. OGAWA T, Inoue T, Kasahara K, Konishi M, et al
    Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    PLoS One. 2020;15:e0230329.
    PubMed     Abstract available


  146. LAPUENTE D, Stab V, Storcksdieck Genannt Bonsmann M, Maaske A, et al
    Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.
    PLoS One. 2020;15:e0231138.
    PubMed     Abstract available


  147. O'CONNELL CM, Jasperse B, Hagen CJ, Titong A, et al
    Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
    PLoS One. 2020;15:e0230711.
    PubMed     Abstract available


  148. LI AJ, Tabu C, Shendale S, Okoth PO, et al
    Qualitative insights into reasons for missed opportunities for vaccination in Kenyan health facilities.
    PLoS One. 2020;15:e0230783.
    PubMed     Abstract available


  149. SCHRIJVERS-GONLAG M, Skarpe C, Andreassen HP
    Influence of light availability and soil productivity on insect herbivory on bilberry (Vaccinium myrtillus L.) leaves following mammalian herbivory.
    PLoS One. 2020;15:e0230509.
    PubMed     Abstract available


  150. LAURETTI-FERREIRA F, Silva PLD, Alcantara NM, Silva BF, et al
    New strategies for Leptospira vaccine development based on LPS removal.
    PLoS One. 2020;15:e0230460.
    PubMed     Abstract available


  151. TUCKERMAN J, Crawford NW, Marshall HS
    Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
    PLoS One. 2020;15:e0230425.
    PubMed     Abstract available


  152. BAHEMUKA UM, Abaasa A, Seeley J, Byaruhanga M, et al
    Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study.
    PLoS One. 2020;15:e0231640.
    PubMed     Abstract available


  153. LEUKER C, Samartzidis L, Hertwig R, Pleskac TJ, et al
    When money talks: Judging risk and coercion in high-paying clinical trials.
    PLoS One. 2020;15:e0227898.
    PubMed     Abstract available


  154. ACEVEDO-VILLANUEVA KY, Lester B, Renu S, Han Y, et al
    Efficacy of chitosan-based nanoparticle vaccine administered to broiler birds challenged with Salmonella.
    PLoS One. 2020;15:e0231998.
    PubMed     Abstract available


  155. LEE MF, Chen YH, Song PP, Lin TM, et al
    Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy.
    PLoS One. 2020;15:e0232042.
    PubMed     Abstract available


  156. ADAM A, Fusheini A
    Knowledge, risk of infection, and vaccination status of hepatitis B virus among rural high school students in Nanumba North and South Districts of Ghana.
    PLoS One. 2020;15:e0231930.
    PubMed     Abstract available


  157. OPANDA S, Bulimo W, Gachara G, Ekuttan C, et al
    Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene.
    PLoS One. 2020;15:e0228029.
    PubMed     Abstract available


  158. STEFANOFF P, Sobierajski T, Bulinska-Stangrecka H, Augustynowicz E, et al
    Exploring factors improving support for vaccinations among Polish primary care physicians.
    PLoS One. 2020;15:e0232722.
    PubMed     Abstract available


  159. SARKER AR, Islam Z, Sultana M, Sheikh N, et al
    Willingness to pay for oral cholera vaccines in urban Bangladesh.
    PLoS One. 2020;15:e0232600.
    PubMed     Abstract available


  160. PARZYCH EM, Miura K, Long CA, Burns JM Jr, et al
    Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
    PLoS One. 2020;15:e0232355.
    PubMed     Abstract available


  161. POTLURI R, Kumar A, Maheshwari V, Smith C, et al
    Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis.
    PLoS One. 2020;15:e0230406.
    PubMed     Abstract available


  162. GODFREY O, Zhang W, Amponsem-Boateng C, Bonney Oppong T, et al
    Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis.
    PLoS One. 2020;15:e0232113.
    PubMed     Abstract available


  163. RIMAL S, Ojha KC, Chaisowwong W, Shah Y, et al
    Detection of virus-neutralising antibodies and associated factors against rabies in the vaccinated household dogs of Kathmandu Valley, Nepal.
    PLoS One. 2020;15:e0231967.
    PubMed     Abstract available


  164. RYYTI R, Hamalainen M, Peltola R, Moilanen E, et al
    Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity.
    PLoS One. 2020;15:e0232605.
    PubMed     Abstract available


  165. CUMMINGS CL, Kong WY, Orminski J
    A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore.
    PLoS One. 2020;15:e0232472.
    PubMed     Abstract available


  166. MANSILLA FC, Turco CS, Miraglia MC, Bessone FA, et al
    The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    PLoS One. 2020;15:e0232782.
    PubMed     Abstract available


  167. BENNETT DE, Meyler KL, Cafferkey MT, Cunney RJ, et al
    Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.
    PLoS One. 2020;15:e0228629.
    PubMed     Abstract available


  168. LIM W, Zhang P
    Herd immunity and a vaccination game: An experimental study.
    PLoS One. 2020;15:e0232652.
    PubMed     Abstract available


  169. ITO H, Nishimura H, Kisu T, Hagiwara H, et al
    Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.
    PLoS One. 2020;15:e0233001.
    PubMed     Abstract available


  170. SPRYGIN A, Pestova Y, Bjadovskaya O, Prutnikov P, et al
    Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease.
    PLoS One. 2020;15:e0232584.
    PubMed     Abstract available


  171. NAMAKULA R, de Bree LCJ, A Tvedt TH, Netea MG, et al
    Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and beta-glucan.
    PLoS One. 2020;15:e0229287.
    PubMed     Abstract available


  172. CASTRO JT, Oliveira GS, Nishigasako MA, Debrie AS, et al
    Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    PLoS One. 2020;15:e0228055.
    PubMed     Abstract available


  173. CREPEY P, Redondo E, Diez-Domingo J, Ortiz de Lejarazu R, et al
    From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
    PLoS One. 2020;15:e0233526.
    PubMed     Abstract available


  174. MUNGWIRA RG, Guillard C, Saldana A, Okabe N, et al
    Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries.
    PLoS One. 2020;15:e0233334.
    PubMed     Abstract available


  175. CHANGOLKAR S, Rewley J, Balachandran M, Rareshide CAL, et al
    Phenotyping physician practice patterns and associations with response to a nudge in the electronic health record for influenza vaccination: A quasi-experimental study.
    PLoS One. 2020;15:e0232895.
    PubMed     Abstract available


  176. MBOUMBA BOUASSA RS, Pere H, Gubavu C, Prazuck T, et al
    Serum and cervicovaginal IgG immune responses against alpha7 and alpha9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.
    PLoS One. 2020;15:e0233084.
    PubMed     Abstract available


  177. SANCHEZ JN, Hudgens BR
    Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis).
    PLoS One. 2020;15:e0232705.
    PubMed     Abstract available


  178. SARKER AR, Sultana M
    Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh.
    PLoS One. 2020;15:e0233902.
    PubMed     Abstract available


  179. LI SW, Wright M, Healey JF, Hutchinson JM, et al
    Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
    PLoS One. 2020;15:e0233866.
    PubMed     Abstract available


  180. ANDERSON JD 4TH, Pecenka CJ, Bagamian KH, Rheingans RD, et al
    Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    PLoS One. 2020;15:e0232941.
    PubMed     Abstract available


  181. MPENDO J, Mutua G, Nanvubya A, Anzala O, et al
    Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
    PLoS One. 2020;15:e0233151.
    PubMed     Abstract available


  182. BASAK S, Kang HJ, Lee SH, Chu KB, et al
    Influenza vaccine efficacy induced by orally administered recombinant baculoviruses.
    PLoS One. 2020;15:e0233520.
    PubMed     Abstract available


  183. LEITE JA, Resende P, Araya JL, Barrera GB, et al
    Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018.
    PLoS One. 2020;15:e0227962.
    PubMed     Abstract available


  184. TUCCI P, Portela M, Chetto CR, Gonzalez-Sapienza G, et al
    Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate.
    PLoS One. 2020;15:e0221837.
    PubMed     Abstract available


  185. LUDWIG G, Garcia-Garcia S, Lanaspa M, Ciruela P, et al
    Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain.
    PLoS One. 2020;15:e0228612.
    PubMed     Abstract available


  186. MAHUMUD RA, Alam K, Keramat SA, Ormsby GM, et al
    Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2020;15:e0233499.
    PubMed     Abstract available


  187. ARCHER RA, Kapoor R, Isaranuwatchai W, Teerawattananon Y, et al
    'It takes two to tango': Bridging the gap between country need and vaccine product innovation.
    PLoS One. 2020;15:e0233950.
    PubMed     Abstract available


  188. CARPP LN, Fong Y, Bonaparte M, Moodie Z, et al
    Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
    PLoS One. 2020;15:e0234236.
    PubMed     Abstract available


  189. BROWNSTONE S, Connor A, Stein D
    Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.
    PLoS One. 2020;15:e0233149.
    PubMed     Abstract available


  190. BLESER WK, Salmon DA, Miranda PY
    A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines.
    PLoS One. 2020;15:e0234466.
    PubMed     Abstract available


  191. OKOLI GN, Lam OLT, Racovitan F, Reddy VK, et al
    Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors.
    PLoS One. 2020;15:e0234702.
    PubMed     Abstract available


  192. SETIAWAN D, Andrijono, Hadinegoro SR, Meyta H, et al
    Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    PLoS One. 2020;15:e0230359.
    PubMed     Abstract available


  193. JOBLING MG, Poole ST, Rasulova-Lewis F, O'Dowd A, et al
    Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
    PLoS One. 2020;15:e0230138.
    PubMed     Abstract available


  194. BUCHINSKY FJ, Ruszkay N, Valentino W, Derkay CS, et al
    In RRP, serologic response to HPV is frequently absent and slow to develop.
    PLoS One. 2020;15:e0230106.
    PubMed     Abstract available


  195. BWALYA P, Hang'ombe BM, Gamil AA, Munang'andu HM, et al
    A whole-cell Lactococcus garvieae autovaccine protects Nile tilapia against infection.
    PLoS One. 2020;15:e0230739.
    PubMed     Abstract available


  196. KILICH E, Dada S, Francis MR, Tazare J, et al
    Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0234827.
    PubMed     Abstract available


  197. SSEKAMATTE T, Mukama T, Kibira SPS, Ndejjo R, et al
    Hepatitis B screening and vaccination status of healthcare providers in Wakiso district, Uganda.
    PLoS One. 2020;15:e0235470.
    PubMed     Abstract available


  198. CHOJNACKY M, Rodriguez AL
    Effect of thermal ballast loading on temperature stability of domestic refrigerators used for vaccine storage.
    PLoS One. 2020;15:e0235777.
    PubMed     Abstract available


  199. DUMAS EK, Demiraslan H, Ingram RJ, Sparks RM, et al
    Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    PLoS One. 2020;15:e0230782.
    PubMed     Abstract available


  200. SONG D, Qi F, Liu S, Tang Z, et al
    The adoptive transfer of BCG-induced T lymphocytes contributes to hippocampal cell proliferation and tempers anxiety-like behavior in immune deficient mice.
    PLoS One. 2020;15:e0225874.
    PubMed     Abstract available


  201. NEAL EFG, Nguyen CD, Ratu FT, Dunne EM, et al
    Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys.
    PLoS One. 2020;15:e0231041.
    PubMed     Abstract available


  202. KEAY S, Poljak Z, Klapwyk M, O'Connor A, et al
    Influenza A virus vaccine research conducted in swine from 1990 to May 2018: A scoping review.
    PLoS One. 2020;15:e0236062.
    PubMed     Abstract available


  203. BROWNSTONE S, Connor A, Stein D
    Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.
    PLoS One. 2020;15:e0236542.
    PubMed    


  204. HOSKING K, Stewart G, Mobsby M, Skov S, et al
    Data linkage and computerised algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia - Is it feasible?
    PLoS One. 2020;15:e0232207.
    PubMed     Abstract available


  205. BARTOLO S, Mancel O, Deliege E, Carpentier S, et al
    Determinants of pregnant women's knowledge about influenza and the influenza vaccine: A large, single-centre cohort study.
    PLoS One. 2020;15:e0236793.
    PubMed     Abstract available


  206. SOVERI A, Karlsson LC, Maki O, Antfolk J, et al
    Trait reactance and trust in doctors as predictors of vaccination behavior, vaccine attitudes, and use of complementary and alternative medicine in parents of young children.
    PLoS One. 2020;15:e0236527.
    PubMed     Abstract available


  207. MUKANDAVIRE Z, Nyabadza F, Malunguza NJ, Cuadros DF, et al
    Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios.
    PLoS One. 2020;15:e0236003.
    PubMed     Abstract available


  208. BAKER L, Matthiopoulos J, Muller T, Freuling C, et al
    Local rabies transmission and regional spatial coupling in European foxes.
    PLoS One. 2020;15:e0220592.
    PubMed     Abstract available


  209. WU Q, Jia M, Chen H, Zhang S, et al
    The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study.
    PLoS One. 2020;15:e0232129.
    PubMed     Abstract available


  210. PIRALAM B, Prosperi C, Thamthitiwat S, Bunthi C, et al
    Pneumococcal colonization prevalence and density among Thai children with severe pneumonia and community controls.
    PLoS One. 2020;15:e0232151.
    PubMed     Abstract available


  211. ECKSTEIN C, Mol JPS, Costa FB, Nunes PP, et al
    Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.
    PLoS One. 2020;15:e0231893.
    PubMed     Abstract available


  212. SABAHELZAIN MM, Dube E, Moukhyer M, Larson HJ, et al
    Psychometric properties of the adapted measles vaccine hesitancy scale in Sudan.
    PLoS One. 2020;15:e0237171.
    PubMed     Abstract available


  213. RUNGROJCHAROENKIT K, Sunintaboon P, Ellison D, Macareo L, et al
    Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.
    PLoS One. 2020;15:e0237218.
    PubMed     Abstract available


  214. NIKI M, Yoshiyama T, Nagai H, Miyamoto Y, et al
    Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development.
    PLoS One. 2020;15:e0237062.
    PubMed     Abstract available


  215. CABEZAS C, Trujillo O, Balbuena J, Peceros FM, et al
    Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
    PLoS One. 2020;15:e0236993.
    PubMed     Abstract available


  216. SARKAR M, Saha S
    Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
    PLoS One. 2020;15:e0237300.
    PubMed     Abstract available


  217. FILICE E, Dube E, Graham JE, MacDonald NE, et al
    Vaccination discourses among chiropractors, naturopaths and homeopaths: A qualitative content analysis of academic literature and Canadian organizational webpages.
    PLoS One. 2020;15:e0236691.
    PubMed     Abstract available


  218. DE VILLIERS MJ, Gamkrelidze I, Hallett TB, Nayagam S, et al
    Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models.
    PLoS One. 2020;15:e0237525.
    PubMed     Abstract available


  219. BARUTI K, Lentz K, Anderson M, Ajibola G, et al
    Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    PLoS One. 2020;15:e0237252.
    PubMed     Abstract available


  220. AALEMI AK, Shahpar K, Mubarak MY
    Factors influencing vaccination coverage among children age 12-23 months in Afghanistan: Analysis of the 2015 Demographic and Health Survey.
    PLoS One. 2020;15:e0236955.
    PubMed     Abstract available


  221. BARAL R, Fleming J, Khan S, Higgins D, et al
    Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage.
    PLoS One. 2020;15:e0237718.
    PubMed     Abstract available


  222. LI AJ, Tabu C, Shendale S, Sergon K, et al
    Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
    PLoS One. 2020;15:e0237913.
    PubMed     Abstract available


  223. PARKINSON LV, Mulder CPH
    Patterns of pollen and resource limitation of fruit production in Vaccinium uliginosum and V. vitis-idaea in Interior Alaska.
    PLoS One. 2020;15:e0224056.
    PubMed     Abstract available


  224. HASAN M, Azim KF, Imran MAS, Chowdhury IM, et al
    Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach.
    PLoS One. 2020;15:e0237181.
    PubMed     Abstract available


  225. URABE CT, Tanaka G, Oshima T, Maruyama A, et al
    Comparing catch-up vaccination programs based on analysis of 2012-13 rubella outbreak in Kawasaki City, Japan.
    PLoS One. 2020;15:e0237312.
    PubMed     Abstract available


  226. FISHER BS, Dambrauskas N, Trakhimets O, Andrade DV, et al
    Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates.
    PLoS One. 2020;15:e0233577.
    PubMed     Abstract available


  227. CHO HK, Hwang SH, Nam HN, Han K, et al
    Incidence of intussusception before and after the introduction of rotavirus vaccine in Korea.
    PLoS One. 2020;15:e0238185.
    PubMed     Abstract available


  228. ESCHLE S, Hartmann K, Rieger A, Fischer S, et al
    Canine vaccination in Germany: A survey of owner attitudes and compliance.
    PLoS One. 2020;15:e0238371.
    PubMed     Abstract available


  229. ASHHAB AA, Rodin H, Campos M, Abu-Sulb A, et al
    Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection.
    PLoS One. 2020;15:e0237398.
    PubMed     Abstract available


  230. OBERLANDER B, Failing K, Jungst CM, Neuhaus N, et al
    Evaluation of Newcastle Disease antibody titers in backyard poultry in Germany with a vaccination interval of twelve weeks.
    PLoS One. 2020;15:e0238068.
    PubMed     Abstract available


  231. MUTISYA EM, Mutua G, Nyasani D, Nduta H, et al
    Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    PLoS One. 2020;15:e0238028.
    PubMed     Abstract available


  232. ZEDDEMAN A, van Schuppen E, Kok KE, van Gent M, et al
    Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.
    PLoS One. 2020;15:e0237394.
    PubMed     Abstract available


  233. ROCKLIFFE L, Stearns S, Forster AS
    A qualitative exploration of using financial incentives to improve vaccination uptake via consent form return in female adolescents in London.
    PLoS One. 2020;15:e0237805.
    PubMed     Abstract available


  234. ABESIG J, Chen Y, Wang H, Sompo FM, et al
    Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0234348.
    PubMed     Abstract available


  235. AKAMATSU MA, Sakihara VA, Carvalho BP, de Paiva Abrantes A, et al
    Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil.
    PLoS One. 2020;15:e0233632.
    PubMed     Abstract available


  236. REUBEN R, Aitken D, Freedman JL, Einstein G, et al
    Mistrust of the medical profession and higher disgust sensitivity predict parental vaccine hesitancy.
    PLoS One. 2020;15:e0237755.
    PubMed     Abstract available


  237. ZHAO XN, Zhang HJ, Li D, Zhou JN, et al
    Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018.
    PLoS One. 2020;15:e0234869.
    PubMed     Abstract available


  238. SWAIN JK, Carpio Y, Johansen LH, Velazquez J, et al
    Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.).
    PLoS One. 2020;15:e0239827.
    PubMed     Abstract available


  239. JEMBERU WT, Molla W, Dagnew T, Rushton J, et al
    Farmers' willingness to pay for foot and mouth disease vaccine in different cattle production systems in Amhara region of Ethiopia.
    PLoS One. 2020;15:e0239829.
    PubMed     Abstract available


  240. BUDU E, Darteh EKM, Ahinkorah BO, Seidu AA, et al
    Trend and determinants of complete vaccination coverage among children aged 12-23 months in Ghana: Analysis of data from the 1998 to 2014 Ghana Demographic and Health Surveys.
    PLoS One. 2020;15:e0239754.
    PubMed     Abstract available


  241. KAMEI K, Miyairi I, Ishikura K, Ogura M, et al
    Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
    PLoS One. 2020;15:e0240217.
    PubMed     Abstract available


  242. SCHMITT-VAN DE LEEMPUT E, Metcalfe LVA, Caldow G, Walz PH, et al
    Comparison of milk production of dairy cows vaccinated with a live double deleted BVDV vaccine and non-vaccinated dairy cows cohabitating in commercial herds endemically infected with BVD virus.
    PLoS One. 2020;15:e0240113.
    PubMed     Abstract available


  243. VADLAMUDI NK, Patrick DM, Hoang L, Sadarangani M, et al
    Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
    PLoS One. 2020;15:e0239848.
    PubMed     Abstract available


  244. CHUNG GS, Hutton DW
    Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.
    PLoS One. 2020;15:e0239926.
    PubMed     Abstract available


  245. NOWAK SA, Chen C, Parker AM, Gidengil CA, et al
    Comparing covariation among vaccine hesitancy and broader beliefs within Twitter and survey data.
    PLoS One. 2020;15:e0239826.
    PubMed     Abstract available


  246. HUGHES HE, Elliot AJ, Hughes TC, Hungerford D, et al
    Using emergency department syndromic surveillance to investigate the impact of a national vaccination program: A retrospective observational study.
    PLoS One. 2020;15:e0240021.
    PubMed     Abstract available


  247. KUMAR A, Misra S, Verma V, Vishwakarma RK, et al
    Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
    PLoS One. 2020;15:e0240710.
    PubMed     Abstract available


  248. HUON JF, Gregoire A, Meireles A, Lefebvre M, et al
    Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    PLoS One. 2020;15:e0234693.
    PubMed     Abstract available


  249. LI J, Yu W, Zhao Z, Zhang L, et al
    Measles vaccination among children in border areas of Yunnan Province, Southwest China.
    PLoS One. 2020;15:e0240733.
    PubMed     Abstract available


  250. FOIS A, Boucher-Lafleur AM, Thompson Legault J, Renaud C, et al
    Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients.
    PLoS One. 2020;15:e0239860.
    PubMed     Abstract available


  251. BONNEVIE E, Rosenberg SD, Kummeth C, Goldbarg J, et al
    Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine.
    PLoS One. 2020;15:e0240828.
    PubMed     Abstract available


  252. AGYEI-BAFFOUR P, Asare M, Lanning B, Koranteng A, et al
    Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model.
    PLoS One. 2020;15:e0240657.
    PubMed     Abstract available


  253. DEGAREGE A, Krupp K, Srinivas V, Ibrahimou B, et al
    Structural equation modeling to detect correlates of childhood vaccination: A moderated mediation analysis.
    PLoS One. 2020;15:e0240749.
    PubMed     Abstract available


  254. COHEN ND, Cywes-Bentley C, Kahn SM, Bordin AI, et al
    Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi.
    PLoS One. 2020;15:e0240479.
    PubMed     Abstract available


  255. KHAIRKHAH N, Aghasadeghi MR, Namvar A, Bolhassani A, et al
    Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
    PLoS One. 2020;15:e0240577.
    PubMed     Abstract available


  256. ANDERSON MS, Niemuth NA, Sabourin CL, Badorrek CS, et al
    Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
    PLoS One. 2020;15:e0238196.
    PubMed     Abstract available


  257. TSAI MH, Liao SL, Chiu CY, Shih HJ, et al
    Longitudinal investigation of nasopharyngeal pneumococcal carriage in early childhood: The PATCH birth cohort study.
    PLoS One. 2020;15:e0237871.
    PubMed     Abstract available


  258. KANDEIL A, Gomaa MR, El Taweel A, Mostafa A, et al
    Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
    PLoS One. 2020;15:e0241471.
    PubMed     Abstract available


  259. AWOKE N, Mulgeta H, Lolaso T, Tekalign T, et al
    Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241226.
    PubMed     Abstract available


  260. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    PubMed     Abstract available


  261. NOEL G, Badmasti F, Nikbin VS, Zahraei SM, et al
    Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    PLoS One. 2020;15:e0238398.
    PubMed     Abstract available


  262. GURNANI V, Singh P, Haldar P, Aggarwal MK, et al
    Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).
    PLoS One. 2020;15:e0241369.
    PubMed     Abstract available


  263. VILCHES TN, Shoukat A, Ferreira CP, Moghadas SM, et al
    Projecting influenza vaccine effectiveness: A simulation study.
    PLoS One. 2020;15:e0241549.
    PubMed     Abstract available


  264. WHITE ER, Hebert-Dufresne L
    State-level variation of initial COVID-19 dynamics in the United States.
    PLoS One. 2020;15:e0240648.
    PubMed     Abstract available


  265. ARAUJO LO, Nunes AMPB, Ferreira VM, Cardoso CW, et al
    Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016.
    PLoS One. 2020;15:e0238932.
    PubMed     Abstract available


  266. DE MUNTER AC, Ruijs WLM, Ruiter RAC, van Nimwegen DJJ, et al
    Decision-making on maternal pertussis vaccination among women in a vaccine-hesitant religious group: Stages and needs.
    PLoS One. 2020;15:e0242261.
    PubMed     Abstract available


  267. GOMES JM, Silva BM, Santos EFS, Kelly PJ, et al
    Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance.
    PLoS One. 2020;15:e0241674.
    PubMed     Abstract available


  268. SHAHZAMAL M, Mans B, Hoog F, Paini D, et al
    Vaccination strategies on dynamic networks with indirect transmission links and limited contact information.
    PLoS One. 2020;15:e0241612.
    PubMed     Abstract available


  269. CARANNANTE A, Fazio C, Neri A, Lista F, et al
    Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.
    PLoS One. 2020;15:e0241793.
    PubMed     Abstract available


  270. KAZIMBAYA KM, Chisenga CC, Simuyandi M, Phiri CM, et al
    In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    PLoS One. 2020;15:e0240714.
    PubMed     Abstract available


  271. VEZINA B, Petit GA, Martin JL, Halili MA, et al
    Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets.
    PLoS One. 2020;15:e0241306.
    PubMed     Abstract available


  272. CASPE SG, Livingstone M, Frew D, Aitchison K, et al
    The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection.
    PLoS One. 2020;15:e0242526.
    PubMed     Abstract available


  273. SHRESTHA DB, Khadka M, Khadka M, Subedi P, et al
    Hepatitis B vaccination status and knowledge, attitude, and practice regarding Hepatitis B among preclinical medical students of a medical college in Nepal.
    PLoS One. 2020;15:e0242658.
    PubMed     Abstract available


  274. BAYU H, Elias B, Abdisa S, Tune A, et al
    Post exposure prophylaxis coverage, vertical transmission and associated factors among hepatitis B exposed newborns delivered at Arsi zone health institutions, 2019.
    PLoS One. 2020;15:e0238987.
    PubMed     Abstract available


  275. HAVLICEK DF, Rosenberg JB, De BP, Hicks MJ, et al
    Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
    PLoS One. 2020;15:e0239780.
    PubMed     Abstract available


  276. GONZALEZ-BLOCK MA, Gutierrez-Calderon E, Pelcastre-Villafuerte BE, Arroyo-Laguna J, et al
    Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates.
    PLoS One. 2020;15:e0243833.
    PubMed     Abstract available


  277. WHANG YH, Kim SK, Yoon H, Choi SK, et al
    Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
    PLoS One. 2020;15:e0243909.
    PubMed     Abstract available


  278. LUCIDARME J, Zhu B, Xu L, Bai X, et al
    Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage.
    PLoS One. 2020;15:e0243426.
    PubMed     Abstract available


  279. KAJUNGU D, Muhoozi M, Stark J, Weibel D, et al
    Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach.
    PLoS One. 2020;15:e0243834.
    PubMed     Abstract available


  280. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    PubMed     Abstract available



  281. Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    PLoS One. 2020;15:e0244011.
    PubMed    


  282. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    PLoS One. 2020;15:e0242502.
    PubMed     Abstract available


  283. VEGA-POLO P, Cobo MM, Argudo A, Gutierrez B, et al
    Characterizing the genetic diversity of the Andean blueberry (Vaccinium floribundum Kunth.) across the Ecuadorian Highlands.
    PLoS One. 2020;15:e0243420.
    PubMed     Abstract available


  284. CHIMOYI L, Velen K, Churchyard GJ, Wallis R, et al
    An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
    PLoS One. 2020;15:e0243707.
    PubMed     Abstract available



  285. Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
    PLoS One. 2020;15:e0244074.
    PubMed    


  286. CARCELEN AC, Hayford K, Moss WJ, Book C, et al
    How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.
    PLoS One. 2020;15:e0240734.
    PubMed     Abstract available


  287. TAHIR UL QAMAR M, Rehman A, Tusleem K, Ashfaq UA, et al
    Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    PLoS One. 2020;15:e0244176.
    PubMed     Abstract available


  288. AJIBOLA G, Bennett K, Powis KM, Hughes MD, et al
    Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    PLoS One. 2020;15:e0244100.
    PubMed     Abstract available


  289. DE LEMOS APS, Sacchi CT, Goncalves CR, Camargo CH, et al
    Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
    PLoS One. 2020;15:e0243375.
    PubMed     Abstract available


  290. FUDOLIG M, Howard R
    The local stability of a modified multi-strain SIR model for emerging viral strains.
    PLoS One. 2020;15:e0243408.
    PubMed     Abstract available


  291. JIANG W, Pilkington EH, Kelly HG, Tan HX, et al
    Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem.
    PLoS One. 2020;15:e0241649.
    PubMed     Abstract available


  292. BELL S, Clarke R, Paterson P, Mounier-Jack S, et al
    Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England.
    PLoS One. 2020;15:e0244049.
    PubMed     Abstract available


  293. BERRY DA, Berry S, Hale P, Isakov L, et al
    A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
    PLoS One. 2020;15:e0244418.
    PubMed     Abstract available


  294. BOZIO CH, Isenhour C, McNamara LA
    Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States.
    PLoS One. 2020;15:e0241989.
    PubMed     Abstract available


  295. DO PC, Nguyen TH, Vo UHM, Le L, et al
    iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus.
    PLoS One. 2020;15:e0239112.
    PubMed     Abstract available


  296. TALAAT KR, Porter CK, Jaep KM, Duplessis CA, et al
    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
    PLoS One. 2020;15:e0239888.
    PubMed     Abstract available


  297. MENIKOU S, McArdle AJ, Li MS, Kaforou M, et al
    A proteomics-based method for identifying antigens within immune complexes.
    PLoS One. 2020;15:e0244157.
    PubMed     Abstract available


  298. MUWONGE R, Basu P, Gheit T, Anantharaman D, et al
    Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
    PLoS One. 2020;15:e0244242.
    PubMed     Abstract available


    January 2019
  299. ZEBERTAVAGE L, Bambina S, Shugart J, Alice A, et al
    A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
    PLoS One. 2019;14:e0209153.
    PubMed     Abstract available


  300. HODGINS B, Pillet S, Landry N, Ward BJ, et al
    A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities.
    PLoS One. 2019;14:e0210009.
    PubMed     Abstract available


  301. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0210081.
    PubMed     Abstract available


  302. PERNICIARO S, Imohl M, Fitzner C, van der Linden M, et al
    Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.
    PLoS One. 2019;14:e0210278.
    PubMed     Abstract available


  303. LEE YY, Wang Z
    Facilitators and barriers for healthcare providers to recommend HPV vaccination to attendees of public sexually transmitted diseases clinics in Hong Kong, China.
    PLoS One. 2019;14:e0209942.
    PubMed     Abstract available


  304. ATCHESON E, Bauza K, Reyes-Sandoval A
    A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.
    PLoS One. 2019;14:e0209028.
    PubMed     Abstract available


  305. NYARI S, Booth R, Quigley BL, Waugh CA, et al
    Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
    PLoS One. 2019;14:e0210245.
    PubMed     Abstract available


  306. YOU JHS, Ming WK, Tsang OT, Chan PK, et al
    Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.
    PLoS One. 2019;14:e0210005.
    PubMed     Abstract available


  307. KISLAYA I, Rodrigues AP, Sousa-Uva M, Gomez V, et al
    Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
    PLoS One. 2019;14:e0209428.
    PubMed     Abstract available


  308. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    PubMed     Abstract available


  309. BAHEMUKA UM, Abaasa A, Ruzagira E, Lindan C, et al
    Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    PLoS One. 2019;14:e0198460.
    PubMed     Abstract available


  310. OGBUANU IU, Li AJ, Anya BM, Tamadji M, et al
    Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology.
    PLoS One. 2019;14:e0210648.
    PubMed     Abstract available


  311. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    PubMed     Abstract available


  312. PRIMO ME, Thompson CS, Valentini BS, Sarli M, et al
    Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.
    PLoS One. 2019;14:e0211149.
    PubMed     Abstract available


  313. HOULE SKD, Eurich DT
    Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.
    PLoS One. 2019;14:e0211006.
    PubMed     Abstract available


  314. CUI J, O'Connell CM, Costa A, Pan Y, et al
    A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0208801.
    PubMed     Abstract available


  315. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    PubMed     Abstract available


  316. CASAL J, Saegerman C, Bertagnoli S, Meyer G, et al
    A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
    PLoS One. 2019;14:e0210317.
    PubMed     Abstract available


  317. ESPANA G, Hogea C, Guignard A, Ten Bosch QA, et al
    Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.
    PLoS One. 2019;14:e0210041.
    PubMed     Abstract available


  318. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    PubMed     Abstract available


  319. MARTINEZ L, Milanic M, Malaina I, Alvarez C, et al
    Weighted lambda superstrings applied to vaccine design.
    PLoS One. 2019;14:e0211714.
    PubMed     Abstract available


  320. KIM HW, Lee HY, Kim SE, Ahn HY, et al
    Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea.
    PLoS One. 2019;14:e0211475.
    PubMed     Abstract available


  321. LEVY C, Varon E, Ouldali N, Wollner A, et al
    Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
    PLoS One. 2019;14:e0211712.
    PubMed     Abstract available


  322. CHAKRABARTI A, Grepin KA, Helleringer S
    The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    PLoS One. 2019;14:e0212049.
    PubMed     Abstract available


  323. MEDISE BE, Soedjatmiko S, Rengganis I, Gunardi H, et al
    Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
    PLoS One. 2019;14:e0211784.
    PubMed     Abstract available


  324. WILDE S, Jiang Y, Tafoya AM, Horsman J, et al
    Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
    PLoS One. 2019;14:e0197721.
    PubMed     Abstract available


  325. CUI J, O'Connell CM, Costa A, Pan Y, et al
    Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0213091.
    PubMed     Abstract available


  326. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    PubMed     Abstract available


  327. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    PubMed     Abstract available


  328. ALCOLEA PJ, Alonso A, Esteban A, Peris P, et al
    IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.
    PLoS One. 2019;14:e0212136.
    PubMed     Abstract available


  329. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0212957.
    PubMed     Abstract available


  330. NGOCHO JS, Magoma B, Olomi GA, Mahande MJ, et al
    Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.
    PLoS One. 2019;14:e0212295.
    PubMed     Abstract available


  331. BOULTON ML, Carlson BF, Wagner AL, Porth JM, et al
    Vaccination timeliness among newborns and infants in Ethiopia.
    PLoS One. 2019;14:e0212408.
    PubMed     Abstract available


  332. TUMIOTTO C, Alves BM, Recordon-Pinson P, Jourdain M, et al
    Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    PLoS One. 2019;14:e0212347.
    PubMed     Abstract available


  333. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Abstract available


  334. KELLY JD, Worden L, Wannier SR, Hoff NA, et al
    Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of Congo, as of May 27, 2018.
    PLoS One. 2019;14:e0213190.
    PubMed     Abstract available


  335. SRIVASTAV A, O'Halloran A, Lu PJ, Williams WW, et al
    Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015.
    PLoS One. 2019;14:e0213431.
    PubMed     Abstract available


  336. KIM HJ, Son HS, Lee SW, Yoon Y, et al
    Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    PLoS One. 2019;14:e0210477.
    PubMed     Abstract available


  337. VAN DER WEELE P, Breeuwsma M, Donken R, van Logchem E, et al
    Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    PLoS One. 2019;14:e0212927.
    PubMed     Abstract available


  338. DABRAL N, Burcham GN, Jain-Gupta N, Sriranganathan N, et al
    Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    PLoS One. 2019;14:e0213587.
    PubMed     Abstract available


  339. MOHAMMED H, McMillan M, Roberts CT, Marshall HS, et al
    A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.
    PLoS One. 2019;14:e0214538.
    PubMed     Abstract available


  340. THILAKARATHNE DS, Coppo MJC, Hartley CA, Diaz-Mendez A, et al
    Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    PLoS One. 2019;14:e0213866.
    PubMed     Abstract available


  341. MUNUSAMY PONNAN S, Pattabiram S, Thiruvengadam K, Goyal R, et al
    Induction and maintenance of bi-functional (IFN-gamma + IL-2+ and IL-2+ TNF-alpha+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2019;14:e0213911.
    PubMed     Abstract available


  342. MWANGOME M, Ngari M, Bwahere P, Kabore P, et al
    Anthropometry at birth and at age of routine vaccination to predict mortality in the first year of life: A birth cohort study in BukinaFaso.
    PLoS One. 2019;14:e0213523.
    PubMed     Abstract available


  343. BERNSTEIN DI, Cardin RD, Pullum DA, Bravo FJ, et al
    Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
    PLoS One. 2019;14:e0213401.
    PubMed     Abstract available


  344. WIBABARA Y, Banura C, Kalyango J, Karamagi C, et al
    Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.
    PLoS One. 2019;14:e0214732.
    PubMed     Abstract available


  345. MAENETJE P, Lindan C, Makkan H, Chetty-Makkan CM, et al
    HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    PLoS One. 2019;14:e0214786.
    PubMed     Abstract available


  346. VUPPUTURI S, Rubenstein KB, Derus AJ, Loftus BC, et al
    Factors contributing to racial disparities in influenza vaccinations.
    PLoS One. 2019;14:e0213972.
    PubMed     Abstract available


  347. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    PubMed     Abstract available


  348. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.
    PLoS One. 2019;14:e0215125.
    PubMed     Abstract available


  349. WILLIAMS LBA, Fry LM, Herndon DR, Franceschi V, et al
    A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    PLoS One. 2019;14:e0215605.
    PubMed     Abstract available


  350. MOONSAMY S, Suchard M, Madhi SA
    Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    PLoS One. 2019;14:e0215079.
    PubMed     Abstract available


  351. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Abstract available


  352. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
    PLoS One. 2019;14:e0215321.
    PubMed     Abstract available


  353. LOUBET P, Nguyen C, Burnet E, Launay O, et al
    Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives.
    PLoS One. 2019;14:e0215251.
    PubMed     Abstract available


  354. BERTOLDO G, Pesce A, Pepe A, Pelullo CP, et al
    Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy.
    PLoS One. 2019;14:e0215978.
    PubMed     Abstract available


  355. PEASAH SK, Meltzer MI, Vu M, Moulia DL, et al
    Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    PLoS One. 2019;14:e0213499.
    PubMed     Abstract available


  356. YUAN Q, Wang F, Zheng H, Zhang G, et al
    Hepatitis B vaccination coverage among health care workers in China.
    PLoS One. 2019;14:e0216598.
    PubMed     Abstract available


  357. MASONOU T, Hokey DA, Lahey T, Halliday A, et al
    CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    PLoS One. 2019;14:e0217091.
    PubMed     Abstract available


  358. VERHEES RAF, Thijs C, Ambergen T, Dinant GJ, et al
    Influenza vaccination in the elderly: 25 years follow-up of a randomized controlled trial. No impact on long-term mortality.
    PLoS One. 2019;14:e0216983.
    PubMed     Abstract available


  359. SEGURA M, Lopez-Gigosos R, Mariscal-Lopez E, Gutierrez-Bedmar M, et al
    Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017.
    PLoS One. 2019;14:e0217588.
    PubMed     Abstract available


  360. ALFONSO VH, Bratcher A, Ashbaugh H, Doshi R, et al
    Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo.
    PLoS One. 2019;14:e0217426.
    PubMed     Abstract available


  361. PILLET S, Couillard J, Trepanier S, Poulin JF, et al
    Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >/=50 years old adults.
    PLoS One. 2019;14:e0216533.
    PubMed     Abstract available


  362. BIDDLECOME A, Habte HH, McGrath KM, Sambanthamoorthy S, et al
    Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles.
    PLoS One. 2019;14:e0215031.
    PubMed     Abstract available


  363. MBOUMBA BOUASSA RS, Nodjikouambaye ZA, Sadjoli D, Adawaye C, et al
    High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    PLoS One. 2019;14:e0217486.
    PubMed     Abstract available


  364. KOS S, Lopes A, Preat V, Cemazar M, et al
    Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
    PLoS One. 2019;14:e0217762.
    PubMed     Abstract available


  365. TEMBO T, Simuyandi M, Chiyenu K, Sharma A, et al
    Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    PLoS One. 2019;14:e0215972.
    PubMed     Abstract available


  366. SAGIYEV Z, Berdibekov A, Bolger T, Merekenova A, et al
    Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.
    PLoS One. 2019;14:e0218366.
    PubMed     Abstract available


  367. LUNA BM, Nielsen TB, Cheng B, Pantapalangkoor P, et al
    Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    PLoS One. 2019;14:e0217439.
    PubMed     Abstract available


  368. WANGMO K, Laven R, Cliquet F, Wasniewski M, et al
    Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan.
    PLoS One. 2019;14:e0209946.
    PubMed     Abstract available


  369. SABAHELZAIN MM, Moukhyer M, Dube E, Hardan A, et al
    Towards a further understanding of measles vaccine hesitancy in Khartoum state, Sudan: A qualitative study.
    PLoS One. 2019;14:e0213882.
    PubMed     Abstract available


  370. RAGHAVA MOHAN V, Raj S, Dhingra MS, Aloysia D'Cor N, et al
    Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    PLoS One. 2019;14:e0218033.
    PubMed     Abstract available


  371. KANG HJ, Chu KB, Lee DH, Lee SH, et al
    Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs.
    PLoS One. 2019;14:e0216871.
    PubMed     Abstract available


  372. DESHEVA Y, Leontieva G, Kramskaya T, Grabovskaya KB, et al
    Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections.
    PLoS One. 2019;14:e0218544.
    PubMed     Abstract available



  373. Retraction: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    PLoS One. 2019;14:e0218050.
    PubMed    


  374. WU HH, Chang YY, Kuo SC, Chen YT, et al
    Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    PLoS One. 2019;14:e0219172.
    PubMed     Abstract available


  375. OBIRI-YEBOAH D, Awuku YA, Adjei G, Cudjoe O, et al
    Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana.
    PLoS One. 2019;14:e0219148.
    PubMed     Abstract available


  376. STENZEL T, Dziewulska D, Smialek M, Tykalowski B, et al
    Comparison of the immune response to vaccination with pigeon circovirus recombinant capsid protein (PiCV rCP) in pigeons uninfected and subclinically infected with PiCV.
    PLoS One. 2019;14:e0219175.
    PubMed     Abstract available


  377. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental pneumococcal vaccine for mucosal immunization.
    PLoS One. 2019;14:e0218679.
    PubMed     Abstract available


  378. ADAMU AA, Uthman OA, Gadanya MA, Adetokunboh OO, et al
    A multilevel analysis of the determinants of missed opportunities for vaccination among children attending primary healthcare facilities in Kano, Nigeria: Findings from the pre-implementation phase of a collaborative quality improvement programme.
    PLoS One. 2019;14:e0218572.
    PubMed     Abstract available


  379. MIYASHITA Y, Ishikawa K, Fukushima Y, Kouwaki T, et al
    Immune-regulatory microRNA expression levels within circulating extracellular vesicles correspond with the appearance of local symptoms after seasonal flu vaccination.
    PLoS One. 2019;14:e0219510.
    PubMed     Abstract available


  380. KIM MH, Kim HJ, Chang J
    Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    PLoS One. 2019;14:e0220196.
    PubMed     Abstract available


  381. ALESSANDRINI V, Anselem O, Girault A, Mandelbrot L, et al
    Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
    PLoS One. 2019;14:e0220705.
    PubMed     Abstract available


  382. BRICOUT H, Torcel-Pagnon L, Lecomte C, Almas MF, et al
    Determinants of shingles vaccine acceptance in the United Kingdom.
    PLoS One. 2019;14:e0220230.
    PubMed     Abstract available


  383. VAN DER LINDEN M, Imohl M, Perniciaro S
    Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2019;14:e0220453.
    PubMed     Abstract available


  384. ANDRESEN AMS, Lutfi E, Ruyter B, Berge G, et al
    Interaction between dietary fatty acids and genotype on immune response in Atlantic salmon (Salmo salar) after vaccination: A transcriptome study.
    PLoS One. 2019;14:e0219625.
    PubMed     Abstract available


  385. SCHMEDT N, Schiffner-Rohe J, Sprenger R, Walker J, et al
    Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
    PLoS One. 2019;14:e0220848.
    PubMed     Abstract available


  386. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    PubMed     Abstract available


  387. CAMPBELL ZA, Thumbi SM, Marsh TL, Quinlan MB, et al
    Why isn't everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania.
    PLoS One. 2019;14:e0220963.
    PubMed     Abstract available


  388. JEONG S, Jang EJ, Jo J, Jang S, et al
    Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis.
    PLoS One. 2019;14:e0220910.
    PubMed     Abstract available


  389. WOLFSON LJ, Daniels VJ, Pillsbury M, Kurugol Z, et al
    Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    PLoS One. 2019;14:e0220921.
    PubMed     Abstract available


  390. FRALEIGH NL, Oliva R, Lewicky JD, Martel AL, et al
    Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
    PLoS One. 2019;14:e0221708.
    PubMed     Abstract available


  391. DRURY RE, Pollard AJ, O'Connor D
    The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies.
    PLoS One. 2019;14:e0221143.
    PubMed     Abstract available


  392. MAREFIAW TA, Yenesew MA, Mihirete KM
    Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.
    PLoS One. 2019;14:e0218470.
    PubMed     Abstract available


  393. FERRERAS E, Matapo B, Chizema-Kawesha E, Chewe O, et al
    Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    PLoS One. 2019;14:e0219040.
    PubMed     Abstract available


  394. BITSOUNI V, Lycett S, Opriessnig T, Doeschl-Wilson A, et al
    Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs.
    PLoS One. 2019;14:e0220738.
    PubMed     Abstract available


  395. JUSTWAN F, Baumgaertner B, Carlisle JE, Carson E, et al
    The effect of trust and proximity on vaccine propensity.
    PLoS One. 2019;14:e0220658.
    PubMed     Abstract available


  396. NAKATUDDE I, Rujumba J, Namiiro F, Sam A, et al
    Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda.
    PLoS One. 2019;14:e0221902.
    PubMed     Abstract available


  397. KRAMSKAYA T, Leontieva G, Desheva Y, Grabovskaya K, et al
    Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.
    PLoS One. 2019;14:e0222148.
    PubMed     Abstract available


  398. VON MOLLENDORF C, La Vincente S, Ulziibayar M, Suuri B, et al
    Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016.
    PLoS One. 2019;14:e0222423.
    PubMed     Abstract available


  399. CHAN JA, Wetzel D, Reiling L, Miura K, et al
    Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    PLoS One. 2019;14:e0221733.
    PubMed     Abstract available


  400. ISLAM MA, Neuhoff C, Aqter Rony S, Grosse-Brinkhaus C, et al
    PBMCs transcriptome profiles identified breed-specific transcriptome signatures for PRRSV vaccination in German Landrace and Pietrain pigs.
    PLoS One. 2019;14:e0222513.
    PubMed     Abstract available


  401. BRAEYE T, Bauchau V, Sturkenboom M, Emborg HD, et al
    Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    PLoS One. 2019;14:e0222296.
    PubMed     Abstract available


  402. CARTER C, Houser KV, Yamshchikov GV, Bellamy AR, et al
    Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
    PLoS One. 2019;14:e0222178.
    PubMed     Abstract available


  403. MACICAME I, Bhatt N, Matavele Chissumba R, Eller LA, et al
    HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique.
    PLoS One. 2019;14:e0221682.
    PubMed     Abstract available


  404. SISTERE-ORO M, Lopez-Serrano S, Veljkovic V, Pina-Pedrero S, et al
    DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
    PLoS One. 2019;14:e0222201.
    PubMed     Abstract available


  405. DIAZ-GARCIA L, Rodriguez-Bonilla L, Phillips M, Lopez-Hernandez A, et al
    Comprehensive analysis of the internal structure and firmness in American cranberry (Vaccinium macrocarpon Ait.) fruit.
    PLoS One. 2019;14:e0222451.
    PubMed     Abstract available


  406. KRAFT C, Hennies R, Dreckmann K, Noguera M, et al
    Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity.
    PLoS One. 2019;14:e0223060.
    PubMed     Abstract available


  407. MONAMELE CG, Munshili Njifon HL, Vernet MA, Njankouo MR, et al
    Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2019;14:e0210119.
    PubMed     Abstract available


  408. COETZER A, Gwenhure L, Makaya P, Markotter W, et al
    Epidemiological aspects of the persistent transmission of rabies during an outbreak (2010 - 2017) in Harare, Zimbabwe.
    PLoS One. 2019;14:e0210018.
    PubMed     Abstract available


  409. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    PubMed     Abstract available



  410. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    PubMed     Abstract available


  411. ENERLY E, Flingtorp R, Christiansen IK, Campbell S, et al
    An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0223612.
    PubMed     Abstract available


  412. NAGANT C, Barbezange C, Dedeken L, Besse-Hammer T, et al
    Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.
    PLoS One. 2019;14:e0223991.
    PubMed     Abstract available


  413. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2019;14:e0223658.
    PubMed     Abstract available


  414. KATO H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, et al
    Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
    PLoS One. 2019;14:e0223684.
    PubMed     Abstract available


  415. AL-OMAR HA, Sherif HM, Mayet AY
    Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.
    PLoS One. 2019;14:e0223594.
    PubMed     Abstract available


  416. MARTINEZ-VEGA R, Jauneikaite E, Thoon KC, Chua HY, et al
    Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: A need to expand vaccination policy?
    PLoS One. 2019;14:e0220951.
    PubMed     Abstract available


  417. STAUFT CB, Yang C, Coleman JR, Boltz D, et al
    Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
    PLoS One. 2019;14:e0223784.
    PubMed     Abstract available


  418. BRADHURST R, Garner G, East I, Death C, et al
    Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    PLoS One. 2019;14:e0223518.
    PubMed     Abstract available


  419. WU CY, Yu SL, Chen YT, Chen YH, et al
    The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.
    PLoS One. 2019;14:e0210553.
    PubMed     Abstract available


  420. JIANG L, Tian X, Peng D, Zhang L, et al
    HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    PLoS One. 2019;14:e0210311.
    PubMed     Abstract available


  421. CLOTHIER HJ, Lawrie J, Russell MA, Kelly H, et al
    Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia.
    PLoS One. 2019;14:e0224702.
    PubMed     Abstract available


  422. KARLSSON LC, Lewandowsky S, Antfolk J, Salo P, et al
    The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers.
    PLoS One. 2019;14:e0224330.
    PubMed     Abstract available


  423. HANSEN NS, Byberg S, Jacobsen LH, Bjerregaard-Andersen M, et al
    Correction: Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau.
    PLoS One. 2019;14:e0224782.
    PubMed     Abstract available


  424. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    PubMed     Abstract available


  425. LA TM, Choi EJ, Lee JB, Park SY, et al
    Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
    PLoS One. 2019;14:e0211158.
    PubMed     Abstract available


  426. COLAMESTA V, Tamburrano A, Barbara A, Gentili A, et al
    Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study.
    PLoS One. 2019;14:e0225326.
    PubMed     Abstract available


  427. KIL LP, Vaneman J, van der Lubbe JEM, Czapska-Casey D, et al
    Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice.
    PLoS One. 2019;14:e0225063.
    PubMed     Abstract available


  428. RYT-HANSEN P, Pedersen AG, Larsen I, Krog JS, et al
    Acute Influenza A virus outbreak in an enzootic infected sow herd: Impact on viral dynamics, genetic and antigenic variability and effect of maternally derived antibodies and vaccination.
    PLoS One. 2019;14:e0224854.
    PubMed     Abstract available


  429. IZQUIERDO-LARA R, Chumbe A, Calderon K, Fernandez-Diaz M, et al
    Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
    PLoS One. 2019;14:e0209539.
    PubMed     Abstract available


  430. LI C, Xu J, Deng Y, Sun H, et al
    Selection of reference genes for normalization of cranberry (Vaccinium macrocarpon Ait.) gene expression under different experimental conditions.
    PLoS One. 2019;14:e0224798.
    PubMed     Abstract available


  431. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.
    PLoS One. 2019;14:e0224831.
    PubMed     Abstract available


  432. ERCIBENGOA M, Alonso M, Vicente D, Morales M, et al
    Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping.
    PLoS One. 2019;14:e0212022.
    PubMed     Abstract available


  433. SHENGE JA, Odaibo GN, Olaleye DO
    Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    PLoS One. 2019;14:e0210724.
    PubMed     Abstract available


  434. THIELMANN A, Puth MT, Kersting C, Porz J, et al
    Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study).
    PLoS One. 2019;14:e0224972.
    PubMed     Abstract available


  435. QI L, Su K, Xia Y, Tang W, et al
    Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017.
    PLoS One. 2019;14:e0225569.
    PubMed     Abstract available


  436. SISTERE-ORO M, Vergara-Alert J, Stratmann T, Lopez-Serrano S, et al
    Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
    PLoS One. 2019;14:e0212431.
    PubMed     Abstract available


  437. MIR RA, Schaut RG, Allen HK, Looft T, et al
    Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonizationtravel.
    PLoS One. 2019;14:e0226099.
    PubMed     Abstract available


  438. THIELMANN A, Puth MT, Weltermann B
    Visual inspection of vaccine storage conditions in general practices: A study of 75 vaccine refrigerators.
    PLoS One. 2019;14:e0225764.
    PubMed     Abstract available



  439. Expression of Concern: Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
    PLoS One. 2019;14:e0226124.
    PubMed    


  440. HEINSON AI, Ewing RM, Holloway JW, Woelk CH, et al
    An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction.
    PLoS One. 2019;14:e0226256.
    PubMed     Abstract available



  441. Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0226706.
    PubMed     Abstract available


  442. ABDO Z, LeCureux J, LaVoy A, Eklund B, et al
    Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice.
    PLoS One. 2019;14:e0225842.
    PubMed     Abstract available



  443. Correction: Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonization.
    PLoS One. 2019;14:e0227403.
    PubMed     Abstract available


  444. COTE-GRAVEL J, Brouillette E, Malouin F
    Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus.
    PLoS One. 2019;14:e0227109.
    PubMed     Abstract available


  445. LOUKA C, Chandler E, Ranchor AV, Broer H, et al
    Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.
    PLoS One. 2019;14:e0226948.
    PubMed     Abstract available


  446. CRAM JA, Fiore-Gartland AJ, Srinivasan S, Karuna S, et al
    Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.
    PLoS One. 2019;14:e0225622.
    PubMed     Abstract available


  447. LATTHAPHASAVANG V, Vanhems P, Ngo-Giang-Huong N, Sibounlang P, et al
    Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study.
    PLoS One. 2019;14:e0215011.
    PubMed     Abstract available


  448. BLEVINS TP, Yu Y, Belshe RB, Bellamy AR, et al
    Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.
    PLoS One. 2019;14:e0214467.
    PubMed     Abstract available


  449. LI Y, Tang X, Zhao Z, Wang H, et al
    Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection.
    PLoS One. 2019;14:e0214596.
    PubMed     Abstract available


  450. ALHARBI A, Rabadi SM, Alqahtani M, Marghani D, et al
    Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis.
    PLoS One. 2019;14:e0213699.
    PubMed     Abstract available


  451. SHIMBASHI R, Chang B, Tanabe Y, Takeda H, et al
    Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.
    PLoS One. 2019;14:e0212418.
    PubMed     Abstract available


  452. OLIVEIRA A, Selvaraj K, Tripathy JP, Betodkar U, et al
    Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research.
    PLoS One. 2019;14:e0226141.
    PubMed     Abstract available


  453. SEO H, Nandre RM, Nietfeld J, Chen Z, et al
    Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
    PLoS One. 2019;14:e0216076.
    PubMed     Abstract available


  454. ARZT J, Fish I, Pauszek SJ, Johnson SL, et al
    The evolution of a super-swarm of foot-and-mouth disease virus in cattle.
    PLoS One. 2019;14:e0210847.
    PubMed     Abstract available


  455. CHENG C, Xu K, Kong R, Chuang GY, et al
    Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
    PLoS One. 2019;14:e0215163.
    PubMed     Abstract available


  456. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam.
    PLoS One. 2019;14:e0208154.
    PubMed     Abstract available


  457. MATVEEV AL, Kozlova IV, Stronin OV, Khlusevich YA, et al
    Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    PLoS One. 2019;14:e0215075.
    PubMed     Abstract available


  458. PATEL JS, Quates CJ, Johnson EL, Ytreberg FM, et al
    Expanding the watch list for potential Ebola virus antibody escape mutations.
    PLoS One. 2019;14:e0211093.
    PubMed     Abstract available


  459. RISTIC M, Milosevic V, Medic S, Djekic Malbasa J, et al
    Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    PLoS One. 2019;14:e0216219.
    PubMed     Abstract available


  460. PRABDIAL-SING N, Makhathini L, Smit SB, Manamela MJ, et al
    Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.
    PLoS One. 2019;14:e0217415.
    PubMed     Abstract available


  461. HOLMES CL, Peyton CG, Bier AM, Donlon TZ, et al
    Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.
    PLoS One. 2019;14:e0217221.
    PubMed     Abstract available


  462. AO Z, Wang L, Mendoza EJ, Cheng K, et al
    Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
    PLoS One. 2019;14:e0216949.
    PubMed     Abstract available


  463. NDIZEYE Z, Vanden Broeck D, Lebelo RL, Bogers J, et al
    Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    PLoS One. 2019;14:e0209303.
    PubMed     Abstract available


  464. DE GIER B, van Kassel MN, Sanders EAM, van de Beek D, et al
    Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
    PLoS One. 2019;14:e0216749.
    PubMed     Abstract available


  465. WANG L, Tan Y, Wei C, Zhang H, et al
    A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide.
    PLoS One. 2019;14:e0218427.
    PubMed     Abstract available


  466. STASHKO LA, Gacic-Dobo M, Dumolard LB, Danovaro-Holliday MC, et al
    Assessing the quality and accuracy of national immunization program reported target population estimates from 2000 to 2016.
    PLoS One. 2019;14:e0216933.
    PubMed     Abstract available


  467. CARDOSO AM, Resende PC, Paixao ES, Tavares FG, et al
    Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
    PLoS One. 2019;14:e0218925.
    PubMed     Abstract available


  468. BHUIYAN MS, Hossain M, Sharmin S, Shirin A, et al
    Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).
    PLoS One. 2019;14:e0218353.
    PubMed     Abstract available


  469. QURESHI S, Ahmad K, Fatima P, Hassan RM, et al
    Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
    PLoS One. 2019;14:e0219324.
    PubMed     Abstract available


  470. CAINI S, Kusznierz G, Garate VV, Wangchuk S, et al
    The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
    PLoS One. 2019;14:e0222381.
    PubMed     Abstract available


  471. WANG W, Vassell R, Song HS, Chen Q, et al
    Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    PLoS One. 2019;14:e0222436.
    PubMed     Abstract available


  472. SABRI A, Quistrebert J, Naji Amrani H, Abid A, et al
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    PLoS One. 2019;14:e0221081.
    PubMed     Abstract available


  473. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam.
    PLoS One. 2019;14:e0223733.
    PubMed     Abstract available


  474. LIND A, Akel O, Wallenius M, Ramelius A, et al
    HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
    PLoS One. 2019;14:e0222882.
    PubMed     Abstract available


  475. KUROSAWA Y, Sato S, Okuyama T, Taoka M, et al
    Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns.
    PLoS One. 2019;14:e0222199.
    PubMed     Abstract available


  476. LAI CC, Weng TC, Tseng YF, Chiang JR, et al
    Evaluation of novel disposable bioreactors on pandemic influenza virus production.
    PLoS One. 2019;14:e0220803.
    PubMed     Abstract available


  477. POTTER GE, Wong J, Sugimoto J, Diallo A, et al
    Networks of face-to-face social contacts in Niakhar, Senegal.
    PLoS One. 2019;14:e0220443.
    PubMed     Abstract available


  478. HAU SJ, Mou KT, Bayles DO, Brockmeier SL, et al
    Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar.
    PLoS One. 2019;14:e0220365.
    PubMed     Abstract available


  479. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Abstract available


  480. DUNNE EM, Choummanivong M, Neal EFG, Stanhope K, et al
    Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR.
    PLoS One. 2019;14:e0224392.
    PubMed     Abstract available


  481. NJOUOM R, Monamele CG, Munshili Njifon HL, Kenmoe S, et al
    Circulation of influenza virus from 2009 to 2018 in Cameroon: 10 years of surveillance data.
    PLoS One. 2019;14:e0225793.
    PubMed     Abstract available


  482. CHANDRA J, Woo WP, Dutton JL, Xu Y, et al
    Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial.
    PLoS One. 2019;14:e0226320.
    PubMed     Abstract available


  483. WIJAYASRI S, Hillier K, Lim GH, Harris TM, et al
    The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.
    PLoS One. 2019;14:e0226353.
    PubMed     Abstract available


  484. TAPIA F, Wohlfarth D, Sandig V, Jordan I, et al
    Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    PLoS One. 2019;14:e0224317.
    PubMed     Abstract available


  485. NEJO YT, Olaleye DO, Odaibo GN
    Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.
    PLoS One. 2019;14:e0224748.
    PubMed     Abstract available


  486. KING HAD, Gonelli CA, Tullett KM, Lahoud MH, et al
    Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
    PLoS One. 2019;14:e0220986.
    PubMed     Abstract available


    January 2018
  487. WU PW, Huang CC, Chao WC, Sun CC, et al
    Impact of influenza vaccine on childhood otitis media in Taiwan: A population-based study.
    PLoS One. 2018;13:e0190507.
    PubMed     Abstract available


  488. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0189571.
    PubMed     Abstract available


  489. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    PubMed     Abstract available


  490. ZUST R, Li SH, Xie X, Velumani S, et al
    Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
    PLoS One. 2018;13:e0189262.
    PubMed     Abstract available


  491. WALLACE RM, Lai Y, Doty JB, Chen CC, et al
    Initial pen and field assessment of baits to use in oral rabies vaccination of Formosan ferret-badgers in response to the re-emergence of rabies in Taiwan.
    PLoS One. 2018;13:e0189998.
    PubMed     Abstract available


  492. MBULAWA ZZA, van Schalkwyk C, Hu NC, Meiring TL, et al
    High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.
    PLoS One. 2018;13:e0190166.
    PubMed     Abstract available


  493. TARIGAN S, Wibowo MH, Indriani R, Sumarningsih S, et al
    Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    PLoS One. 2018;13:e0190947.
    PubMed     Abstract available


  494. CAROLAN K, Verran J, Crossley M, Redfern J, et al
    Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study.
    PLoS One. 2018;13:e0190984.
    PubMed     Abstract available


  495. NOYCE RS, Lederman S, Evans DH
    Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
    PLoS One. 2018;13:e0188453.
    PubMed     Abstract available


  496. HAMMAMI P, Lancelot R, Domenech J, Lesnoff M, et al
    Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa.
    PLoS One. 2018;13:e0190296.
    PubMed     Abstract available


  497. KIM AR, Lee DH, Lee SH, Rubino I, et al
    Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    PLoS One. 2018;13:e0191277.
    PubMed     Abstract available


  498. FERNANDEZ-ARIAS C, Arias CF, Zhang M, Herrero MA, et al
    Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
    PLoS One. 2018;13:e0190940.
    PubMed     Abstract available


  499. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Correction: Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2018;13:e0191378.
    PubMed     Abstract available


  500. LEE YT, Ko EJ, Lee Y, Kim KH, et al
    Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
    PLoS One. 2018;13:e0190868.
    PubMed     Abstract available


  501. BAUMGAERTNER B, Carlisle JE, Justwan F
    The influence of political ideology and trust on willingness to vaccinate.
    PLoS One. 2018;13:e0191728.
    PubMed     Abstract available


  502. KIM H, Kimoto T, Sakai S, Takahashi E, et al
    Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    PLoS One. 2018;13:e0191133.
    PubMed     Abstract available


  503. HARALAMBIEVA IH, Kennedy RB, Simon WL, Goergen KM, et al
    Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.
    PLoS One. 2018;13:e0191812.
    PubMed     Abstract available


  504. OPRIESSNIG T, Gauger PC, Gerber PF, Castro AMMG, et al
    Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
    PLoS One. 2018;13:e0191739.
    PubMed     Abstract available


  505. ALLARD D, Charlebois R, Gilbert L, Stagg J, et al
    CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination.
    PLoS One. 2018;13:e0191973.
    PubMed     Abstract available


  506. TUTYKHINA I, Esmagambetov I, Bagaev A, Pichugin A, et al
    Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    PLoS One. 2018;13:e0191574.
    PubMed     Abstract available


  507. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Abstract available


  508. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    PubMed     Abstract available


  509. GRANDAHL M, Chun Paek S, Grisurapong S, Sherer P, et al
    Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0193054.
    PubMed     Abstract available


  510. VERANI JR, Massora S, Acacio S, Dos Santos RT, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
    PLoS One. 2018;13:e0191113.
    PubMed     Abstract available


  511. GIACOMET V, Masetti M, Nannini P, Forlanini F, et al
    Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.
    PLoS One. 2018;13:e0192638.
    PubMed     Abstract available


  512. WILSON SE, Chung H, Schwartz KL, Guttmann A, et al
    Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    PLoS One. 2018;13:e0192809.
    PubMed     Abstract available


  513. BASKIN E
    Increasing influenza vaccination rates via low cost messaging interventions.
    PLoS One. 2018;13:e0192594.
    PubMed     Abstract available


  514. SHAH MP, Dahl RM, Parashar UD, Lopman BA, et al
    Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States.
    PLoS One. 2018;13:e0191429.
    PubMed     Abstract available


  515. HALL MT, Simms KT, Lew JB, Smith MA, et al
    Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
    PLoS One. 2018;13:e0185332.
    PubMed     Abstract available


  516. KAWAKAMI R, Nozato Y, Nakagami H, Ikeda Y, et al
    Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
    PLoS One. 2018;13:e0191895.
    PubMed     Abstract available


  517. LEE RU, Won SH, Hansen C, Crum-Cianflone NF, et al
    25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population.
    PLoS One. 2018;13:e0192479.
    PubMed     Abstract available


  518. THORRINGTON D, van Rossum L, Knol M, de Melker H, et al
    Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.
    PLoS One. 2018;13:e0192640.
    PubMed     Abstract available


  519. BERKHOUT C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, et al
    Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.
    PLoS One. 2018;13:e0192155.
    PubMed     Abstract available


  520. NEWMAN LP, Bhat N, Fleming JA, Neuzil KM, et al
    Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.
    PLoS One. 2018;13:e0193263.
    PubMed     Abstract available


  521. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0192312.
    PubMed     Abstract available


  522. BISSA M, Forlani G, Zanotto C, Tosi G, et al
    Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.
    PLoS One. 2018;13:e0190869.
    PubMed     Abstract available


  523. SIGAUQUE B, Kobayashi M, Vubil D, Nhacolo A, et al
    Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
    PLoS One. 2018;13:e0191193.
    PubMed     Abstract available


  524. YOSHIKAWA T, Fujii H, Okutani A, Shibamura M, et al
    Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
    PLoS One. 2018;13:e0192725.
    PubMed     Abstract available



  525. Correction: Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2018;13:e0193631.
    PubMed     Abstract available


  526. WOOD PL, Steinman M, Erol E, Carter C, et al
    Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses.
    PLoS One. 2018;13:e0193424.
    PubMed     Abstract available


  527. SCHERER AM, Schacht Reisinger H, Schweizer ML, Askelson NM, et al
    Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States.
    PLoS One. 2018;13:e0193363.
    PubMed     Abstract available


  528. WHITE M, Freistaedter A, Jones GJB, Zervos E, et al
    Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
    PLoS One. 2018;13:e0193131.
    PubMed     Abstract available


  529. XU K, Zhao Q, Wen X, Wu R, et al
    A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
    PLoS One. 2018;13:e0191286.
    PubMed     Abstract available


  530. MOR Z, Amit Aharon A, Sheffer R, Nehama H, et al
    Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis.
    PLoS One. 2018;13:e0193219.
    PubMed     Abstract available


  531. GONZALEZ-SANCHEZ ME, Cuquerella M, Alunda JM
    Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.
    PLoS One. 2018;13:e0193118.
    PubMed     Abstract available


  532. YUEN WWY, Lee A, Chan PKS, Tran L, et al
    Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
    PLoS One. 2018;13:e0194159.
    PubMed     Abstract available


  533. FERNANDO N, Natoli R, Racic T, Wooff Y, et al
    The use of the vaccinia virus complement control protein (VCP) in the rat retina.
    PLoS One. 2018;13:e0193740.
    PubMed     Abstract available


  534. EBRAHIMI-NIK H, Bassami MR, Mohri M, Rad M, et al
    Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
    PLoS One. 2018;13:e0194888.
    PubMed     Abstract available


  535. CASALINO E, Ghazali A, Bouzid D, Antoniol S, et al
    Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.
    PLoS One. 2018;13:e0193029.
    PubMed     Abstract available


  536. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Abstract available


  537. ANDREAE CA, Sessions RB, Virji M, Hill DJ, et al
    Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.
    PLoS One. 2018;13:e0193940.
    PubMed     Abstract available


  538. VISSERS M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, et al
    Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
    PLoS One. 2018;13:e0194823.
    PubMed     Abstract available


  539. NAPOLITANO F, Navaro M, Vezzosi L, Santagati G, et al
    Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.
    PLoS One. 2018;13:e0194920.
    PubMed     Abstract available


  540. HACHIYA M, Miyano S, Mori Y, Vynnycky E, et al
    Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    PLoS One. 2018;13:e0194931.
    PubMed     Abstract available


  541. SHAHID MA, Marenda MS, Markham PF, Noormohammadi AH, et al
    Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics.
    PLoS One. 2018;13:e0194528.
    PubMed     Abstract available


  542. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    PubMed     Abstract available


  543. GRAY DW, Welsh MD, Mansoor F, Doherty S, et al
    DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles.
    PLoS One. 2018;13:e0194488.
    PubMed     Abstract available


  544. TRAMUTO F, Maida CM, Pojero F, Colomba GME, et al
    Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies.
    PLoS One. 2018;13:e0195256.
    PubMed     Abstract available


  545. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    PubMed     Abstract available


  546. OVERTON ET, Lawrence SJ, Wagner E, Nopora K, et al
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
    PLoS One. 2018;13:e0195897.
    PubMed     Abstract available


  547. SHERMAN SM, Nailer E
    Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK.
    PLoS One. 2018;13:e0195801.
    PubMed     Abstract available


  548. ZHOU JJ, Wang YM, Lee VWS, Zhang GY, et al
    DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    PLoS One. 2018;13:e0195657.
    PubMed     Abstract available


  549. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    PubMed     Abstract available


  550. GUARDO AC, Gomez CE, Diaz-Brito V, Pich J, et al
    Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2018;13:e0195915.
    PubMed     Abstract available


  551. GRANDAHL M, Paek SC, Grisurapong S, Sherer P, et al
    Correction: Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0196437.
    PubMed     Abstract available


  552. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0196367.
    PubMed     Abstract available


  553. VAN RAVENHORST MB, den Hartog G, van der Klis FRM, van Rooijen DM, et al
    Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
    PLoS One. 2018;13:e0191261.
    PubMed     Abstract available


  554. MARLET J, Gaudy-Graffin C, Marc D, Boennec R, et al
    Factors associated with influenza vaccination failure and severe disease in a French region in 2015.
    PLoS One. 2018;13:e0195611.
    PubMed     Abstract available


  555. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    PubMed     Abstract available


  556. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    PubMed     Abstract available


  557. VOYSEY M, Pollard AJ, Perera R, Shrestha S, et al
    Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
    PLoS One. 2018;13:e0196200.
    PubMed     Abstract available


  558. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0196546.
    PubMed     Abstract available


  559. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    PubMed     Abstract available


  560. MCCORMICK AA, Shakeel A, Yi C, Kaur H, et al
    Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    PLoS One. 2018;13:e0194614.
    PubMed     Abstract available


  561. GIL DE LOS SANTOS D, Gil de Los Santos JR, Gil-Turnes C, Gaboardi G, et al
    Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens.
    PLoS One. 2018;13:e0192904.
    PubMed     Abstract available


  562. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Abstract available


  563. KHAN A, Junaid M, Kaushik AC, Ali A, et al
    Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
    PLoS One. 2018;13:e0196484.
    PubMed     Abstract available


  564. NUISMER SL, May R, Basinski A, Remien CH, et al
    Controlling epidemics with transmissible vaccines.
    PLoS One. 2018;13:e0196978.
    PubMed     Abstract available


  565. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Abstract available


  566. BUMGARDNER SA, Zhang L, LaVoy AS, Andre B, et al
    Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
    PLoS One. 2018;13:e0196950.
    PubMed     Abstract available


  567. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0196564.
    PubMed     Abstract available


  568. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    PubMed     Abstract available


  569. PAULY M, Black AP, Khampanisong P, Nouanthong P, et al
    Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    PLoS One. 2018;13:e0197370.
    PubMed     Abstract available


  570. MARLEY KB, Kuehn LA, Keele JW, Wileman BW, et al
    Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle.
    PLoS One. 2018;13:e0197347.
    PubMed     Abstract available


  571. MUELLER SW, Baumgartner LJ, MacLaren R, Neumann R, et al
    Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.
    PLoS One. 2018;13:e0197037.
    PubMed     Abstract available


  572. MANOHARAN VK, Varghese BP, Paldurai A, Samal SK, et al
    Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    PLoS One. 2018;13:e0197253.
    PubMed     Abstract available


  573. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    PubMed     Abstract available


  574. HUANG Z, Sun X, Wagner AL, Ren J, et al
    Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.
    PLoS One. 2018;13:e0197437.
    PubMed     Abstract available



  575. Correction: Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0198577.
    PubMed     Abstract available


  576. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    PLoS One. 2018;13:e0198421.
    PubMed     Abstract available


  577. ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
    PLoS One. 2018;13:e0197694.
    PubMed     Abstract available


  578. SHENG X, Liu M, Liu H, Tang X, et al
    Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus).
    PLoS One. 2018;13:e0195450.
    PubMed     Abstract available


  579. LIU M, Huang M, Shui Y, Biville F, et al
    Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1DeltaB739_1343 mutant as an attenuated vaccine.
    PLoS One. 2018;13:e0197310.
    PubMed     Abstract available


  580. CAYROU C, Akinduko AA, Mirkes EM, Lucidarme J, et al
    Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
    PLoS One. 2018;13:e0197186.
    PubMed     Abstract available


  581. KOOIJMAN S, Brummelman J, van Els CACM, Marino F, et al
    Vaccine antigens modulate the innate response of monocytes to Al(OH)3.
    PLoS One. 2018;13:e0197885.
    PubMed     Abstract available


  582. DE PASCALIS R, Hahn A, Brook HM, Ryden P, et al
    A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    PLoS One. 2018;13:e0198140.
    PubMed     Abstract available


  583. SOUTHERN J, Andrews N, Sandu P, Sheppard CL, et al
    Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
    PLoS One. 2018;13:e0195799.
    PubMed     Abstract available


  584. KUCHENBECKER U, Chase D, Reichert A, Schiffner-Rohe J, et al
    Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
    PLoS One. 2018;13:e0197905.
    PubMed     Abstract available


  585. IMAI C, Toizumi M, Hall L, Lambert S, et al
    A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    PLoS One. 2018;13:e0198685.
    PubMed     Abstract available


  586. SHAHRUDIN S, Chen C, David SC, Singleton EV, et al
    Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
    PLoS One. 2018;13:e0198182.
    PubMed     Abstract available


  587. POTTINGER HL, Jacobs ET, Haenchen SD, Ernst KC, et al
    Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
    PLoS One. 2018;13:e0198655.
    PubMed     Abstract available


  588. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    PubMed     Abstract available


  589. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Abstract available


  590. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study.
    PLoS One. 2018;13:e0197374.
    PubMed     Abstract available


  591. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Abstract available


  592. GROPPO R, DiNapoli J, Il Jeong K, Kishko M, et al
    Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
    PLoS One. 2018;13:e0199452.
    PubMed     Abstract available


  593. SU JR, Ng C, Lewis PW, Cano MV, et al
    Adverse events after vaccination among HIV-positive persons, 1990-2016.
    PLoS One. 2018;13:e0199229.
    PubMed     Abstract available


  594. CHIT A, Zivaripiran H, Shin T, Lee JKH, et al
    Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
    PLoS One. 2018;13:e0197970.
    PubMed     Abstract available


  595. CHEUNG T, Lau JTF, Wang JZ, Mo PKH, et al
    Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.
    PLoS One. 2018;13:e0198615.
    PubMed     Abstract available


  596. HORSINGTON J, Nfon C, Bittner H, Durr PA, et al
    The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.
    PLoS One. 2018;13:e0195302.
    PubMed     Abstract available


  597. DE SMEDT T, Merrall E, Macina D, Perez-Vilar S, et al
    Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    PLoS One. 2018;13:e0199180.
    PubMed     Abstract available


  598. NYARI S, Khan SA, Rawlinson G, Waugh CA, et al
    Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    PLoS One. 2018;13:e0200112.
    PubMed     Abstract available


  599. WU AG, Shah AS, Haelle TS, Lunos SA, et al
    Choosing the perfect shot - The loaded narrative of imagery in online news coverage of vaccines.
    PLoS One. 2018;13:e0199870.
    PubMed     Abstract available


  600. ZARNITSYNA VI, Bulusheva I, Handel A, Longini IM, et al
    Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.
    PLoS One. 2018;13:e0199674.
    PubMed     Abstract available


  601. IMAI N, Ferguson NM
    Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.
    PLoS One. 2018;13:e0199450.
    PubMed     Abstract available


  602. KARAMPATSAS K, Osborne L, Seah ML, Tong CYW, et al
    Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study.
    PLoS One. 2018;13:e0194009.
    PubMed     Abstract available


  603. PALING FP, Olsen K, Ohneberg K, Wolkewitz M, et al
    Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
    PLoS One. 2018;13:e0193445.
    PubMed     Abstract available


  604. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    PubMed     Abstract available


  605. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    PubMed     Abstract available


  606. SUBAIYA S, Tabu C, N'ganga J, Awes AA, et al
    Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    PLoS One. 2018;13:e0199786.
    PubMed     Abstract available


  607. SEKULOSKI S, Batzloff MR, Griffin P, Parsonage W, et al
    Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.
    PLoS One. 2018;13:e0198658.
    PubMed     Abstract available


  608. PORTER CK, Lynen A, Riddle MS, Talaat K, et al
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
    PLoS One. 2018;13:e0194325.
    PubMed     Abstract available


  609. LEE KS, Lee YR, Park SY, Oh IH, et al
    The economic burden of rotavirus infection in South Korea from 2009 to 2012.
    PLoS One. 2018;13:e0194120.
    PubMed     Abstract available


  610. JUNG M
    The effect of maternal decisional authority on children's vaccination in East Asia.
    PLoS One. 2018;13:e0200333.
    PubMed     Abstract available


  611. MARBAIX S, Peetermans WE, Verhaegen J, Annemans L, et al
    Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.
    PLoS One. 2018;13:e0199427.
    PubMed     Abstract available


  612. ABDUL-CADER MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, et al
    In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
    PLoS One. 2018;13:e0193964.
    PubMed     Abstract available


  613. GENTILE A, Bakir J, Firpo V, Casanueva EV, et al
    PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.
    PLoS One. 2018;13:e0199989.
    PubMed     Abstract available


  614. MERIKI HD, Tufon KA, Anong DN, Tony NJ, et al
    Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon.
    PLoS One. 2018;13:e0200157.
    PubMed     Abstract available


  615. WEN Y, Trinh HV, Linton CE, Tani C, et al
    Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    PLoS One. 2018;13:e0194266.
    PubMed     Abstract available


  616. GIBSON AD, Mazeri S, Lohr F, Mayer D, et al
    One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns.
    PLoS One. 2018;13:e0200942.
    PubMed     Abstract available


  617. SHEN K, Wasserman M, Liu D, Yang YH, et al
    Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.
    PLoS One. 2018;13:e0201245.
    PubMed     Abstract available


  618. OMINDE M, Sande J, Ooko M, Bottomley C, et al
    Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.
    PLoS One. 2018;13:e0200715.
    PubMed     Abstract available


  619. LEE HS, Thiem VD, Anh DD, Duong TN, et al
    Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015.
    PLoS One. 2018;13:e0194943.
    PubMed     Abstract available


  620. LIANG H, Yang R, Liu Z, Li M, et al
    Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    PLoS One. 2018;13:e0194860.
    PubMed     Abstract available


  621. KAUFMAN J, Ryan R, Hill S
    Qualitative focus groups with stakeholders identify new potential outcomes related to vaccination communication.
    PLoS One. 2018;13:e0201145.
    PubMed     Abstract available


  622. BAKER DL, Powers JG, Ransom JI, McCann BE, et al
    Reimmunization increases contraceptive effectiveness of gonadotropin-releasing hormone vaccine (GonaCon-Equine) in free-ranging horses (Equus caballus): Limitations and side effects.
    PLoS One. 2018;13:e0201570.
    PubMed     Abstract available


  623. LEE MF, Chiang CH, Li YL, Wang NM, et al
    Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.
    PLoS One. 2018;13:e0201281.
    PubMed     Abstract available


  624. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    PubMed     Abstract available


  625. MUNGUAMBE AM, de Almeida AECC, Nhantumbo AA, Come CE, et al
    Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    PLoS One. 2018;13:e0197390.
    PubMed     Abstract available


  626. PURRINOS-HERMIDA MJ, Santiago-Perez MI, Trevino M, Dopazo R, et al
    Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain.
    PLoS One. 2018;13:e0201653.
    PubMed     Abstract available


  627. BROWN DW, Tabu C, Sergon K, Shendale S, et al
    Home-based record (HBR) ownership and use of HBR recording fields in selected Kenyan communities: Results from the Kenya Missed Opportunities for Vaccination Assessment.
    PLoS One. 2018;13:e0201538.
    PubMed     Abstract available


  628. O'ROURKE SM, Byrne G, Tatsuno G, Wright M, et al
    Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
    PLoS One. 2018;13:e0197656.
    PubMed     Abstract available


  629. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Abstract available


  630. POSUWAN N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, et al
    Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    PLoS One. 2018;13:e0202637.
    PubMed     Abstract available


  631. RANFAING J, Dunyach-Remy C, Lavigne JP, Sotto A, et al
    Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli.
    PLoS One. 2018;13:e0202609.
    PubMed     Abstract available


  632. KLYZ A, Piekarowicz A
    Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates.
    PLoS One. 2018;13:e0202437.
    PubMed     Abstract available


  633. TSYBALOVA LM, Stepanova LA, Shuklina MA, Mardanova ES, et al
    Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    PLoS One. 2018;13:e0201429.
    PubMed     Abstract available


  634. MARITAN M, Veggi D, Cozzi R, Dello Iacono L, et al
    Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody.
    PLoS One. 2018;13:e0201922.
    PubMed     Abstract available


  635. AL MAHTAB M, Akbar SMF, Aguilar JC, Guillen G, et al
    Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
    PLoS One. 2018;13:e0201236.
    PubMed     Abstract available



  636. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.
    PubMed    


  637. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    PubMed     Abstract available


  638. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    PubMed     Abstract available


  639. SANAPALA S, Mosca L, Wang S, Curtiss R, et al
    Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.
    PLoS One. 2018;13:e0203526.
    PubMed     Abstract available


  640. VOYSEY M, Sadarangani M, Pollard AJ, Fanshawe TR, et al
    Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias.
    PLoS One. 2018;13:e0202517.
    PubMed     Abstract available


  641. BOZIO CH, Abdul-Karim A, Abenyeri J, Abubakari B, et al
    Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2018;13:e0203205.
    PubMed     Abstract available


  642. HEGERLE N, Choi M, Sinclair J, Amin MN, et al
    Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    PLoS One. 2018;13:e0203143.
    PubMed     Abstract available


  643. MATTHIJSSE SM, Naber SK, Hontelez JAC, Bakker R, et al
    The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
    PLoS One. 2018;13:e0202924.
    PubMed     Abstract available


  644. LI J, Helal ZH, Karch CP, Mishra N, et al
    A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.
    PLoS One. 2018;13:e0203771.
    PubMed     Abstract available


  645. HOWLADER DR, Koley H, Sinha R, Maiti S, et al
    Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
    PLoS One. 2018;13:e0203631.
    PubMed     Abstract available


  646. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Abstract available


  647. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2018;13:e0204759.
    PubMed     Abstract available


  648. ELIZAGA ML, Li SS, Kochar NK, Wilson GJ, et al
    Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
    PLoS One. 2018;13:e0202753.
    PubMed     Abstract available



  649. Correction: Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0204476.
    PubMed     Abstract available


  650. BALOGUN F, Omotade O
    "She must have been sleeping around"...: Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria.
    PLoS One. 2018;13:e0203950.
    PubMed     Abstract available


  651. ALLEN JD, Ray S, Ross TM
    Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0204284.
    PubMed     Abstract available


  652. ROSTAMIAN M, Bahrami F, Niknam HM
    Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    PLoS One. 2018;13:e0204491.
    PubMed     Abstract available


  653. SEMA BALTAZAR C, Rafael F, Langa JPM, Chicumbe S, et al
    Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    PLoS One. 2018;13:e0198592.
    PubMed     Abstract available


  654. SOBHKHEZ M, Krasnov A, Robertsen B
    Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD).
    PLoS One. 2018;13:e0204924.
    PubMed     Abstract available


  655. BAETEN LA, Podell BK, Sluder AE, Garritsen A, et al
    Standardized guinea pig model for Q fever vaccine reactogenicity.
    PLoS One. 2018;13:e0205882.
    PubMed     Abstract available


  656. LAU JTF, Ng CSM, Wu AMS, Ma YL, et al
    Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors.
    PLoS One. 2018;13:e0205561.
    PubMed     Abstract available


  657. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    PubMed     Abstract available


  658. TONUI T, Corredor-Moreno P, Kanduma E, Njuguna J, et al
    Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages.
    PLoS One. 2018;13:e0204047.
    PubMed     Abstract available


  659. ISHIMURA ME, Teixeira D, Silveira GDP, Gambero M, et al
    Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    PLoS One. 2018;13:e0205148.
    PubMed     Abstract available


  660. WHELAN AO, Flick-Smith HC, Homan J, Shen ZT, et al
    Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
    PLoS One. 2018;13:e0200213.
    PubMed     Abstract available


  661. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0205567.
    PubMed     Abstract available


  662. PARK S, Lee Y, Kwon YM, Lee YT, et al
    Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
    PLoS One. 2018;13:e0205071.
    PubMed     Abstract available


  663. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    PubMed     Abstract available


  664. JACKSON ML, Diallo AO, Medah I, Bicaba BW, et al
    Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.
    PLoS One. 2018;13:e0206117.
    PubMed     Abstract available


  665. CHIDUMAYO NN
    System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa.
    PLoS One. 2018;13:e0205884.
    PubMed     Abstract available


  666. CAMPBELL ZA, Marsh TL, Mpolya EA, Thumbi SM, et al
    Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers.
    PLoS One. 2018;13:e0206058.
    PubMed     Abstract available


  667. O'MALLEY KJ, Bowling JL, Stinson E, Cole KS, et al
    Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0205928.
    PubMed     Abstract available


  668. HORACIO AN, Silva-Costa C, Lopes E, Ramirez M, et al
    Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    PLoS One. 2018;13:e0206912.
    PubMed     Abstract available


  669. HOUSER KV, Yamshchikov GV, Bellamy AR, May J, et al
    DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    PLoS One. 2018;13:e0206837.
    PubMed     Abstract available


  670. NYASANI DK, Mutua GN, Sajabi RM, Ng'ang'a JW, et al
    Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    PLoS One. 2018;13:e0206656.
    PubMed     Abstract available


  671. LI X, Doroshenko A, Osgood ND
    Applying particle filtering in both aggregated and age-structured population compartmental models of pre-vaccination measles.
    PLoS One. 2018;13:e0206529.
    PubMed     Abstract available


  672. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    PubMed     Abstract available


  673. ZHAO H, Xu K, Jiang Z, Shao M, et al
    A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.
    PLoS One. 2018;13:e0207431.
    PubMed     Abstract available



  674. Correction: Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0207721.
    PubMed     Abstract available


  675. BECK KB, Honge BL, Olesen JS, Petersen MS, et al
    Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.
    PLoS One. 2018;13:e0207259.
    PubMed     Abstract available


  676. JAIN A, Walker JL, Mathur R, Forbes HJ, et al
    Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.
    PLoS One. 2018;13:e0207183.
    PubMed     Abstract available


  677. STEPHENSON KE, Keefer MC, Bunce CA, Frances D, et al
    First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    PLoS One. 2018;13:e0205139.
    PubMed     Abstract available


  678. WONDIMENEH Y, Tiruneh M, Ferede G, Denekew K, et al
    Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.
    PLoS One. 2018;13:e0207095.
    PubMed     Abstract available


  679. ABU SEIR R, Azmi K, Hamdan A, Namouz H, et al
    Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    PLoS One. 2018;13:e0206927.
    PubMed     Abstract available


  680. MENDES LOBAO W, Duarte FG, Burns JD, de Souza Teles Santos CA, et al
    Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
    PLoS One. 2018;13:e0206726.
    PubMed     Abstract available


  681. MARX M, Zumpe M, Troschke-Meurer S, Shah D, et al
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    PLoS One. 2018;13:e0207320.
    PubMed     Abstract available


  682. VIEGAS EO, Kroidl A, Munseri PJ, Missanga M, et al
    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
    PLoS One. 2018;13:e0206838.
    PubMed     Abstract available


  683. CASSIOLATO AP, Almeida SCG, Andrade AL, Minamisava R, et al
    Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
    PLoS One. 2018;13:e0208211.
    PubMed     Abstract available


  684. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Abstract available


  685. KHAN J, Shil A, Prakash R
    Exploring the spatial heterogeneity in different doses of vaccination coverage in India.
    PLoS One. 2018;13:e0207209.
    PubMed     Abstract available


  686. SONG IG, Lee H, Yi J, Kim MS, et al
    Health literacy and use of preventive health services among North Korean defectors in the Republic of Korea.
    PLoS One. 2018;13:e0195964.
    PubMed     Abstract available


  687. BARBOSA COSTA G, Gilbert A, Monroe B, Blanton J, et al
    The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon.
    PLoS One. 2018;13:e0197330.
    PubMed     Abstract available


  688. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach.
    PLoS One. 2018;13:e0208402.
    PubMed     Abstract available


  689. KORSA MG, Devlin JM, Hartley CA, Browning GF, et al
    Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    PLoS One. 2018;13:e0207611.
    PubMed     Abstract available


  690. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    PLoS One. 2018;13:e0207918.
    PubMed     Abstract available


  691. RUDENKO L, Kiseleva I, Krutikova E, Stepanova E, et al
    Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    PLoS One. 2018;13:e0208028.
    PubMed     Abstract available


  692. FLAMAR AL, Bonnabau H, Zurawski S, Lacabaratz C, et al
    HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
    PLoS One. 2018;13:e0207794.
    PubMed     Abstract available


  693. REN J, Wagner AL, Zheng A, Sun X, et al
    The demographics of vaccine hesitancy in Shanghai, China.
    PLoS One. 2018;13:e0209117.
    PubMed     Abstract available


  694. PASIN C, Halloran ME, Gilbert PB, Langevin E, et al
    Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
    PLoS One. 2018;13:e0207878.
    PubMed     Abstract available


  695. TIONO AB, Nebie I, Anagnostou N, Coulibaly AS, et al
    First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
    PLoS One. 2018;13:e0208328.
    PubMed     Abstract available


  696. SUNAGAR R, Kumar S, Namjoshi P, Rosa SJ, et al
    Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.
    PLoS One. 2018;13:e0207587.
    PubMed     Abstract available


  697. BETSCH C, Schmid P, Heinemeier D, Korn L, et al
    Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.
    PLoS One. 2018;13:e0208601.
    PubMed     Abstract available


  698. ZHANG F, Zhao Q, Quan K, Zhu Z, et al
    Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    PLoS One. 2018;13:e0198207.
    PubMed     Abstract available


  699. KWAN NCL, Yamada A, Sugiura K
    Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.
    PLoS One. 2018;13:e0206717.
    PubMed     Abstract available


  700. HAIWICK G, Hermann J, Roof M, Fergen B, et al
    Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
    PLoS One. 2018;13:e0209784.
    PubMed     Abstract available


  701. KESANOPOULOS K, Bratcher HB, Hong E, Xirogianni A, et al
    Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
    PLoS One. 2018;13:e0209919.
    PubMed     Abstract available


  702. ALLEN JD, Ray S, Ross TM
    Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0210043.
    PubMed     Abstract available


  703. AMPARO ACB, Jayme SI, Roces MCR, Quizon MCL, et al
    The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    PLoS One. 2018;13:e0199186.
    PubMed     Abstract available


  704. DE NARDO P, Gentilotti E, Vairo F, Nguhuni B, et al
    A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination.
    PLoS One. 2018;13:e0197996.
    PubMed     Abstract available


  705. NUNES MC, Weinberg A, Cutland CL, Jones S, et al
    Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    PLoS One. 2018;13:e0210124.
    PubMed     Abstract available


  706. DIMALA CA, Kika BT, Kadia BM, Blencowe H, et al
    Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
    PLoS One. 2018;13:e0209744.
    PubMed     Abstract available


  707. MAKUMBI F, Byabagambi J, Muwanika R, Kigozi G, et al
    Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
    PLoS One. 2018;13:e0209167.
    PubMed     Abstract available


  708. PAES W, Dowle A, Coldwell J, Leech A, et al
    The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions.
    PLoS One. 2018;13:e0198662.
    PubMed     Abstract available


  709. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    PubMed     Abstract available


  710. HOSSAIN MU, Omar TM, Alam I, Das KC, et al
    Pathway based therapeutic targets identification and development of an interactive database CampyNIBase of Campylobacter jejuni RM1221 through non-redundant protein dataset.
    PLoS One. 2018;13:e0198170.
    PubMed     Abstract available


  711. JIANG H, Huai Y, Chen H, Uyeki TM, et al
    Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012.
    PLoS One. 2018;13:e0201312.
    PubMed     Abstract available


  712. NIX EB, Choi J, Anthes C, Gaultier GN, et al
    Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    PLoS One. 2018;13:e0201282.
    PubMed     Abstract available


  713. ACHARYA P, Kismul H, Mapatano MA, Hatloy A, et al
    Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    PLoS One. 2018;13:e0202742.
    PubMed     Abstract available


  714. STADLER J, Naderer L, Beffort L, Ritzmann M, et al
    Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
    PLoS One. 2018;13:e0203560.
    PubMed     Abstract available


  715. PILKERTON CS, Hobbs GR, Lilly C, Knox SS, et al
    Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.
    PLoS One. 2018;13:e0203330.
    PubMed     Abstract available


  716. SARAIVA MMS, Moreira Filho ALB, Freitas Neto OC, Silva NMV, et al
    Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut.
    PLoS One. 2018;13:e0203158.
    PubMed     Abstract available


  717. IN HJ, Lim H, Lee JA, Lee SR, et al
    Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    PLoS One. 2018;13:e0202552.
    PubMed     Abstract available


  718. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    PubMed     Abstract available


  719. CHONG KC, Hu P, Lau S, Jia KM, et al
    Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China.
    PLoS One. 2018;13:e0205339.
    PubMed     Abstract available


  720. CHUNG CJ, Cha SH, Grimm AL, Ajithdoss D, et al
    Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
    PLoS One. 2018;13:e0203482.
    PubMed     Abstract available


  721. ADAMO G, Sturabotti G, Baccolini V, de Soccio P, et al
    Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    PLoS One. 2018;13:e0205147.
    PubMed     Abstract available


  722. ERDEM G, Singh AK, Brusnahan AJ, Moore AN, et al
    Pneumococcal colonization among tracheostomy tube dependent children.
    PLoS One. 2018;13:e0206305.
    PubMed     Abstract available


  723. MATHEW E, Zhu H, Connelly SM, Sullivan MA, et al
    Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    PLoS One. 2018;13:e0205756.
    PubMed     Abstract available


  724. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Abstract available


  725. ALKIE TN, Yitbarek A, Taha-Abdelaziz K, Astill J, et al
    Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    PLoS One. 2018;13:e0206324.
    PubMed     Abstract available


  726. DEBELLUT F, Hendrix N, Ortiz JR, Lambach P, et al
    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
    PLoS One. 2018;13:e0199470.
    PubMed     Abstract available


  727. LAINO J, Villena J, Suvorov A, Zelaya H, et al
    Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    PLoS One. 2018;13:e0206661.
    PubMed     Abstract available


  728. MANNA S, Dunne EM, Ortika BD, Pell CL, et al
    Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.
    PLoS One. 2018;13:e0206622.
    PubMed     Abstract available


  729. YIN R, Tran VH, Zhou X, Zheng J, et al
    Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model.
    PLoS One. 2018;13:e0207777.
    PubMed     Abstract available


  730. VAN DIEPEN MT, Chapman R, Moore PL, Margolin E, et al
    The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.
    PLoS One. 2018;13:e0208310.
    PubMed     Abstract available


  731. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
    PLoS One. 2018;13:e0208267.
    PubMed     Abstract available


  732. MORALES M, Ludwig G, Ercibengoa M, Esteva C, et al
    Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.
    PLoS One. 2018;13:e0209048.
    PubMed     Abstract available


  733. MCSHERRY LA, O'Leary E, Dombrowski SU, Francis JJ, et al
    Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives.
    PLoS One. 2018;13:e0208482.
    PubMed     Abstract available


    January 2017
  734. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    PubMed     Abstract available


  735. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    PubMed     Abstract available


  736. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Abstract available


  737. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Abstract available


  738. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    PubMed     Abstract available


  739. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    PubMed     Abstract available


  740. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    PubMed     Abstract available


  741. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Abstract available


  742. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Abstract available


  743. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    PubMed     Abstract available


  744. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    PubMed     Abstract available


  745. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    PubMed     Abstract available


  746. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    PubMed     Abstract available


  747. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    PubMed     Abstract available


  748. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    PubMed     Abstract available


  749. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    PubMed     Abstract available


  750. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    PubMed     Abstract available


  751. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Abstract available


  752. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Abstract available


  753. HSU AP, Tseng CH, Barrat J, Lee SH, et al
    Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.
    PLoS One. 2017;12:e0184831.
    PubMed     Abstract available


  754. CAPUCCI S, Wee EG, Schiffner T, LaBranche CC, et al
    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
    PLoS One. 2017;12:e0181886.
    PubMed     Abstract available


  755. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Abstract available


  756. PEREZ LG, Martinez DR, deCamp AC, Pinter A, et al
    V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    PLoS One. 2017;12:e0180720.
    PubMed     Abstract available


  757. MINAYA MA, Korom M, Wang H, Belshe RB, et al
    The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
    PLoS One. 2017;12:e0176687.
    PubMed     Abstract available


  758. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Abstract available


  759. FERREYRA-REYES L, Cruz-Hervert LP, Troy SB, Huang C, et al
    Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    PLoS One. 2017;12:e0185594.
    PubMed     Abstract available


  760. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Abstract available


  761. WARD PR, Attwell K, Meyer SB, Rokkas P, et al
    Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia.
    PLoS One. 2017;12:e0185955.
    PubMed     Abstract available


  762. BILLARD MN, De Serres G, Gariepy MC, Boulianne N, et al
    Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
    PLoS One. 2017;12:e0186070.
    PubMed     Abstract available


  763. MCCURLEY NP, Domi A, Basu R, Saunders KO, et al
    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
    PLoS One. 2017;12:e0177863.
    PubMed     Abstract available


  764. SMITH SG, Harris SA, Satti I, Bryan D, et al
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.
    PLoS One. 2017;12:e0184391.
    PubMed     Abstract available


  765. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    PubMed     Abstract available


  766. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Abstract available


  767. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Abstract available


  768. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Abstract available


  769. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Abstract available


  770. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    PubMed     Abstract available


  771. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    PubMed     Abstract available


  772. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    PubMed     Abstract available


  773. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    PubMed     Abstract available


  774. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    PubMed     Abstract available


  775. C GUARDO A, Gomez CE, Diaz-Brito V, Pich J, et al
    Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2017;12:e0186602.
    PubMed     Abstract available


  776. KAZADI EK, Tshilenge GM, Mbao V, Njoumemi Z, et al
    Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo.
    PLoS One. 2017;12:e0186677.
    PubMed     Abstract available


  777. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    PubMed     Abstract available


  778. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Abstract available


  779. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    PubMed     Abstract available


  780. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    PubMed     Abstract available


  781. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    PubMed     Abstract available


  782. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    PubMed     Abstract available


  783. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Abstract available


  784. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    PubMed     Abstract available


  785. CIONCADA R, Maddaluno M, Vo HTM, Woodruff M, et al
    Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    PLoS One. 2017;12:e0185843.
    PubMed     Abstract available


  786. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Abstract available


  787. SASTRY M, Zhang B, Chen M, Joyce MG, et al
    Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
    PLoS One. 2017;12:e0186854.
    PubMed     Abstract available


  788. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    PubMed     Abstract available


  789. FABIANI M, Ferrante G, Minardi V, Giambi C, et al
    Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).
    PLoS One. 2017;12:e0178122.
    PubMed     Abstract available


  790. SORIA I, Quattrocchi V, Langellotti C, Gammella M, et al
    Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.
    PLoS One. 2017;12:e0185184.
    PubMed     Abstract available


  791. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Abstract available


  792. SAMIAK L, Emeto TI
    Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2017;12:e0187796.
    PubMed     Abstract available


  793. ALVAREZ-ZUZEK LG, La Rocca CE, Iglesias JR, Braunstein LA, et al
    Epidemic spreading in multiplex networks influenced by opinion exchanges on vaccination.
    PLoS One. 2017;12:e0186492.
    PubMed     Abstract available


  794. OKU A, Oyo-Ita A, Glenton C, Fretheim A, et al
    Perceptions and experiences of childhood vaccination communication strategies among caregivers and health workers in Nigeria: A qualitative study.
    PLoS One. 2017;12:e0186733.
    PubMed     Abstract available


  795. JAMAL SB, Hassan SS, Tiwari S, Viana MV, et al
    An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.
    PLoS One. 2017;12:e0186401.
    PubMed     Abstract available


  796. DECAMP AC, Rolland M, Edlefsen PT, Sanders-Buell E, et al
    Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
    PLoS One. 2017;12:e0185959.
    PubMed     Abstract available


  797. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Abstract available


  798. HARALAMBIEVA IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, et al
    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
    PLoS One. 2017;12:e0188149.
    PubMed     Abstract available


  799. DE BRUYN J, Thomson PC, Bagnol B, Maulaga W, et al
    The chicken or the egg? Exploring bi-directional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania.
    PLoS One. 2017;12:e0188230.
    PubMed     Abstract available


  800. SOBHKHEZ M, Krasnov A, Chang CJ, Robertsen B, et al
    Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus.
    PLoS One. 2017;12:e0188456.
    PubMed     Abstract available


  801. SENAPATI R, Nayak B, Kar SK, Dwibedi B, et al
    HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    PLoS One. 2017;12:e0187844.
    PubMed     Abstract available


  802. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Abstract available


  803. RALEIGH MD, Peterson SJ, Laudenbach M, Baruffaldi F, et al
    Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
    PLoS One. 2017;12:e0184876.
    PubMed     Abstract available


  804. BOMMANA S, Walker E, Desclozeaux M, Timms P, et al
    Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep.
    PLoS One. 2017;12:e0188370.
    PubMed     Abstract available


  805. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2017;12:e0184540.
    PubMed     Abstract available


  806. KUZNIK A, Iliyasu G, Lamorde M, Mahmud M, et al
    Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    PLoS One. 2017;12:e0188595.
    PubMed     Abstract available



  807. Correction: Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    PLoS One. 2017;12:e0189039.
    PubMed     Abstract available


  808. PRAPHASIRI P, Ditsungnoen D, Sirilak S, Rattanayot J, et al
    Predictors of seasonal influenza vaccination among older adults in Thailand.
    PLoS One. 2017;12:e0188422.
    PubMed     Abstract available


  809. CAYATTE C, Snell Bennett A, Rajani GM, Hostetler L, et al
    Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    PLoS One. 2017;12:e0188708.
    PubMed     Abstract available


  810. CHAISRI U, Tungtrongchitr A, Indrawattana N, Meechan P, et al
    Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.
    PLoS One. 2017;12:e0188627.
    PubMed     Abstract available


  811. XING J, Singh S, Zhao Y, Duan Y, et al
    Increasing vaccine production using pulsed ultrasound waves.
    PLoS One. 2017;12:e0187048.
    PubMed     Abstract available


  812. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
    Promising new vaccine candidates against Campylobacter in broilers.
    PLoS One. 2017;12:e0188472.
    PubMed     Abstract available


  813. MURRAY J, Todd KV, Bakre A, Orr-Burks N, et al
    A universal mammalian vaccine cell line substrate.
    PLoS One. 2017;12:e0188333.
    PubMed     Abstract available


  814. BRUXELLE JF, Mizrahi A, Hoys S, Collignon A, et al
    Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    PLoS One. 2017;12:e0187212.
    PubMed     Abstract available


  815. JEE PF, Tiong V, Shu MH, Khoo JJ, et al
    Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    PLoS One. 2017;12:e0187718.
    PubMed     Abstract available


  816. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Abstract available


  817. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2017;12:e0188807.
    PubMed     Abstract available


  818. KIM YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, et al
    Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector.
    PLoS One. 2017;12:e0189308.
    PubMed     Abstract available


  819. RAJARAM S, Wiecek W, Lawson R, Blak BT, et al
    Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    PLoS One. 2017;12:e0186739.
    PubMed     Abstract available


  820. ARCURI M, Di Benedetto R, Cunningham AF, Saul A, et al
    The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
    PLoS One. 2017;12:e0189100.
    PubMed     Abstract available


  821. MWILA-KAZIMBAYA K, Garcia MP, Bosomprah S, Laban NM, et al
    Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
    PLoS One. 2017;12:e0189351.
    PubMed     Abstract available


  822. PLACE DE, Williamson DR, Yuzefpolskiy Y, Katkere B, et al
    Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.
    PLoS One. 2017;12:e0190384.
    PubMed     Abstract available


  823. MCMORROW ML, Emukule GO, Obor D, Nyawanda B, et al
    Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?
    PLoS One. 2017;12:e0189623.
    PubMed     Abstract available


  824. MWAPE I, Bosomprah S, Mwaba J, Mwila-Kazimbaya K, et al
    Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
    PLoS One. 2017;12:e0187761.
    PubMed     Abstract available


  825. ZORENC Z, Veberic R, Slatnar A, Koron D, et al
    A wild 'albino' bilberry (Vaccinium myrtillus L.) from Slovenia shows three bottlenecks in the anthocyanin pathway and significant differences in the expression of several regulatory genes compared to the common blue berry type.
    PLoS One. 2017;12:e0190246.
    PubMed     Abstract available


  826. KODAY MT, Leonard JA, Munson P, Forero A, et al
    Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
    PLoS One. 2017;12:e0189780.
    PubMed     Abstract available


  827. TARTOF S, Cohn A, Tarbangdo F, Djingarey MH, et al
    Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt.
    PLoS One. 2017;12:e0190188.
    PubMed     Abstract available


  828. SUNTRONWONG N, Klinfueng S, Vichiwattana P, Korkong S, et al
    Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    PLoS One. 2017;12:e0189511.
    PubMed     Abstract available


  829. IKEGAMI T, Balogh A, Nishiyama S, Lokugamage N, et al
    Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.
    PLoS One. 2017;12:e0189250.
    PubMed     Abstract available


  830. BENNETT A, Nagelkerke N, Heinsbroek E, Premkumar PS, et al
    Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres.
    PLoS One. 2017;12:e0190256.
    PubMed     Abstract available


  831. PECENKA C, Munthali S, Chunga P, Levin A, et al
    Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.
    PLoS One. 2017;12:e0190006.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: